# EDGAR Filing Document

**Accession Number:** 0000819793
**File Stem:** 0001628280-25-050028
**Filing Date:** 2025-11
**Character Count:** 158609
**Document Hash:** e9ffcb490bbc44916df2d9d17bc155d7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-050028.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0001628280-25-050028

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 98

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALBANY INTERNATIONAL CORP /DE/
- **CENTRAL INDEX KEY:** 0000819793
- **STANDARD INDUSTRIAL CLASSIFICATION:** BROADWOVEN FABRIC MILS, MAN MADE FIBER & SILK [2221]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 140462060
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10026
- **FILM NUMBER:** 251457306

**BUSINESS ADDRESS:**
- **STREET 1:** 216 AIRPORT DRIVE
- **CITY:** ROCHESTER
- **STATE:** NH
- **ZIP:** 03867
- **BUSINESS PHONE:** 6033305850

**MAIL ADDRESS:**
- **STREET 1:** 216 AIRPORT DRIVE
- **CITY:** ROCHESTER
- **STATE:** NH
- **ZIP:** 03867

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ALBINT INC
- **DATE OF NAME CHANGE:** 19870924

?xml version='1.0' encoding='ASCII'? ain-20250930

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q** 

---

| | | |
|:---|:---|:---|
| ☒ | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | For the quarterly period ended: | September 30, 2025 |

---

OR

---

| | |
|:---|:---|
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | For the transition period from __________ to __________ |

---

**Commission file number: <u>1-10026</u>** 

---

| |
|:---|
| **ALBANY INTERNATIONAL CORP.** |
| (Exact name of registrant as specified in its charter) |

---

**Delaware** 

(State or other jurisdiction of incorporation or organization)

**325 Corporate Drive, Portsmouth, New Hampshire** 

(Address of principal executive offices)

**14-0462060** 

(IRS Employer Identification No.)

**03801** 

(Zip Code)

**603-330-5800** 

(Registrant's telephone number, including area code)

<u>Securities registered pursuant to Section 12(b) of the Act:</u>

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Class A Common Stock, $0.001 par value per share | AIN | The New York Stock Exchange (NYSE) |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer  | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer  | ☐ | Smaller reporting company  | ☐ |
| | | Emerging growth company  | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had 28.7 million shares of Class A Common Stock outstanding as of October 15, 2025.

------

**ALBANY INTERNATIONAL CORP.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page No.** |
| **[Part I Financial information](#i4ea757eceb924ec6b364a53fc8072a64_10)** | **[Part I Financial information](#i4ea757eceb924ec6b364a53fc8072a64_10)** | |
| <u>[Item 1.](#i4ea757eceb924ec6b364a53fc8072a64_13)</u> | <u>[Financial Statements](#i4ea757eceb924ec6b364a53fc8072a64_13)</u> | |
| | <u>[C](#i4ea757eceb924ec6b364a53fc8072a64_16)[onsolidated statements of income – three and](#i4ea757eceb924ec6b364a53fc8072a64_16)</u> nine <u>[months ended](#i4ea757eceb924ec6b364a53fc8072a64_16)</u>September 30, 2025<u>[and](#i4ea757eceb924ec6b364a53fc8072a64_16)</u>2024 | <u>[1](#i4ea757eceb924ec6b364a53fc8072a64_16)</u> |
| | <u>[C](#i4ea757eceb924ec6b364a53fc8072a64_19)[onsolidated statements of comprehensive income/(loss) –](#i4ea757eceb924ec6b364a53fc8072a64_19)</u>three and nine <u>[months ended](#i4ea757eceb924ec6b364a53fc8072a64_19)</u>September 30, 2025<u>[and](#i4ea757eceb924ec6b364a53fc8072a64_16)</u>2024 | <u>[2](#i4ea757eceb924ec6b364a53fc8072a64_19)</u> |
| | <u>[C](#i4ea757eceb924ec6b364a53fc8072a64_22)[onsolidated balance sheets as of](#i4ea757eceb924ec6b364a53fc8072a64_22)</u>September 30, 2025<u>[and](#i4ea757eceb924ec6b364a53fc8072a64_22)</u>December 31, 2024 | <u>[3](#i4ea757eceb924ec6b364a53fc8072a64_22)</u> |
| | <u>[C](#i4ea757eceb924ec6b364a53fc8072a64_25)[onsolidated statements of cash flows –](#i4ea757eceb924ec6b364a53fc8072a64_25)</u>nine<u>[months ended](#i4ea757eceb924ec6b364a53fc8072a64_25)</u>September 30, 2025<u>[and](#i4ea757eceb924ec6b364a53fc8072a64_16)</u>2024 | <u>[4](#i4ea757eceb924ec6b364a53fc8072a64_25)</u> |
| | <u>[Notes to](#i4ea757eceb924ec6b364a53fc8072a64_28)[consolidated financial statements](#i4ea757eceb924ec6b364a53fc8072a64_28)</u> | <u>[5](#i4ea757eceb924ec6b364a53fc8072a64_28)</u> |
| <u>[Item 2.](#i4ea757eceb924ec6b364a53fc8072a64_91)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i4ea757eceb924ec6b364a53fc8072a64_91)</u> | <u>[25](#i4ea757eceb924ec6b364a53fc8072a64_91)</u> |
| | <u>[Forward-looking statements](#i4ea757eceb924ec6b364a53fc8072a64_94)</u> | <u>[25](#i4ea757eceb924ec6b364a53fc8072a64_94)</u> |
| <u>[Item 3.](#i4ea757eceb924ec6b364a53fc8072a64_112)</u> | <u>[Quantitative and Qualitative Disclosures about Market Risk](#i4ea757eceb924ec6b364a53fc8072a64_112)</u> | <u>[36](#i4ea757eceb924ec6b364a53fc8072a64_112)</u> |
| <u>[Item 4.](#i4ea757eceb924ec6b364a53fc8072a64_115)</u> | <u>[Controls and Procedures](#i4ea757eceb924ec6b364a53fc8072a64_115)</u> | <u>[36](#i4ea757eceb924ec6b364a53fc8072a64_115)</u> |
| **[Part II Other Information](#i4ea757eceb924ec6b364a53fc8072a64_118)** | **[Part II Other Information](#i4ea757eceb924ec6b364a53fc8072a64_118)** | |
| <u>[Item 1.](#i4ea757eceb924ec6b364a53fc8072a64_121)</u> | <u>[Legal Proceedings](#i4ea757eceb924ec6b364a53fc8072a64_121)</u> | <u>[37](#i4ea757eceb924ec6b364a53fc8072a64_121)</u> |
| <u>[Item 1A.](#i4ea757eceb924ec6b364a53fc8072a64_124)</u> | <u>[Risk Factors](#i4ea757eceb924ec6b364a53fc8072a64_124)</u> | <u>[37](#i4ea757eceb924ec6b364a53fc8072a64_124)</u> |
| <u>[Item 2.](#i4ea757eceb924ec6b364a53fc8072a64_127)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i4ea757eceb924ec6b364a53fc8072a64_127)</u> | <u>[37](#i4ea757eceb924ec6b364a53fc8072a64_127)</u> |
| <u>[Item 3.](#i4ea757eceb924ec6b364a53fc8072a64_130)</u> | <u>[Defaults upon Senior Securities](#i4ea757eceb924ec6b364a53fc8072a64_130)</u> | <u>[37](#i4ea757eceb924ec6b364a53fc8072a64_130)</u> |
| <u>[Item 4.](#i4ea757eceb924ec6b364a53fc8072a64_133)</u> | <u>[Mine Safety Disclosures](#i4ea757eceb924ec6b364a53fc8072a64_133)</u> | <u>[37](#i4ea757eceb924ec6b364a53fc8072a64_133)</u> |
| <u>[Item 5.](#i4ea757eceb924ec6b364a53fc8072a64_136)</u> | <u>[Other Information](#i4ea757eceb924ec6b364a53fc8072a64_136)</u> | <u>[38](#i4ea757eceb924ec6b364a53fc8072a64_136)</u> |
| <u>[Item 6.](#i4ea757eceb924ec6b364a53fc8072a64_139)</u> | <u>[Exhibits](#i4ea757eceb924ec6b364a53fc8072a64_139)</u> | <u>[39](#i4ea757eceb924ec6b364a53fc8072a64_139)</u> |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

**ITEM 1. FINANCIAL STATEMENTS**

**ALBANY INTERNATIONAL CORP.**

**CONSOLIDATED STATEMENTS OF INCOME/(LOSS)**

**(in thousands, except per share amounts)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net revenues | $261434 | $298386 | $861607 | $943710 |
| Cost of goods sold | 311372 | 208002 | 717552 | 632257 |
| Gross profit/(loss) | (49938) | 90384 | 144055 | 311453 |
| Selling, general, and administrative expenses | 51905 | 52097 | 164219 | 162447 |
| Technical and research expenses | 11467 | 10844 | 35915 | 35369 |
| Restructuring expenses, net | 3197 | 2272 | 9895 | 6584 |
| Operating income/(loss) | (116507) | 25171 | (65974) | 107053 |
| Interest expense/(income), net | 5897 | 2411 | 14702 | 8680 |
| Other expense/(income), net | (347) | 3257 | 4170 | 5932 |
| Income (loss) before income taxes | (122057) | 19503 | (84846) | 92441 |
| Income tax expense/(benefit) | (24419) | 1282 | (13889) | 22131 |
| Net income/(loss) | (97638) | 18221 | (70957) | 70310 |
| Net income/(loss) attributable to the noncontrolling interest | 122 | 192 | 265 | 366 |
| Net income/(loss) attributable to the Company | $(97760) | $18029 | $(71222) | $69944 |
| Earnings per share attributable to Company shareholders - Basic | $(3.37) | $0.58 | $(2.38) | $2.24 |
| Earnings per share attributable to Company shareholders - Diluted | $(3.37) | $0.57 | $(2.38) | $2.23 |
| Shares of the Company used in computing earnings per share: |  |  |  |  |
| Basic | 29012 | 31251 | 29914 | 31234 |
| Diluted | 29012 | 31367 | 29914 | 31333 |
| Dividends declared per Class A share | $0.27 | $0.26 | $0.81 | $0.78 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

**ALBANY INTERNATIONAL CORP.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)**

**(in thousands)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net income/(loss) | $(97638) | $18221 | $(70957) | $70310 |
| Other comprehensive income/(loss), before tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation and other adjustments | 2676 | 16211 | 55948 | (12757) |
| &nbsp;&nbsp;&nbsp;Pension settlement/curtailment |  |  | (1600) |  |
| &nbsp;&nbsp;&nbsp;Amortization of pension liability adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior service credit | (38) | (37) | (112) | (113) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net actuarial loss | 315 | 176 | 908 | 530 |
| &nbsp;&nbsp;&nbsp;Payments and amortization related to interest rate swaps included in earnings | (53) | (2675) | (324) | (10893) |
| &nbsp;&nbsp;&nbsp;Derivative valuation adjustment | 169 | (1238) | (425) | 395 |
| Income taxes related to items of other comprehensive income/(loss): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pension settlement/curtailment |  |  | 422 |  |
| &nbsp;&nbsp;&nbsp;Amortization of prior service credit | 11 | 13 | 34 | 35 |
| &nbsp;&nbsp;&nbsp;Amortization of net actuarial loss | (97) | (55) | (278) | (162) |
| &nbsp;&nbsp;&nbsp;Payments and amortization related to interest rate swaps included in earnings | 17 | 658 | 51 | 2681 |
| &nbsp;&nbsp;&nbsp;Derivative valuation adjustment | (7) | 305 | 67 | (97) |
| &nbsp;&nbsp;&nbsp;Comprehensive income/(loss) | (94645) | 31579 | (16266) | 49929 |
| Comprehensive income/(loss) attributable to the noncontrolling interest | 212 | (127) | 300 | (273) |
| Comprehensive income/(loss) attributable to the Company | $(94857) | $31706 | $(16566) | $50202 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

**ALBANY INTERNATIONAL CORP.**

**CONSOLIDATED BALANCE SHEETS**

**(in thousands, except share and per share data)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)**<br>**September 30, 2025** |<br>**December 31, 2024** |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $108310 | $115283 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 258503 | 246688 |
| &nbsp;&nbsp;&nbsp;Contract assets, net | 140259 | 166557 |
| &nbsp;&nbsp;&nbsp;Inventories | 159664 | 145845 |
| &nbsp;&nbsp;&nbsp;Income taxes prepaid and receivable | 33037 | 19187 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 40758 | 37132 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 740531 | 730692 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 573233 | 563431 |
| &nbsp;&nbsp;&nbsp;Intangibles, net | 36098 | 38127 |
| &nbsp;&nbsp;&nbsp;Goodwill | 184291 | 176261 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 57236 | 28757 |
| &nbsp;&nbsp;&nbsp;Other assets | 110205 | 111428 |
| &nbsp;&nbsp;&nbsp;Total assets | $1701594 | $1648696 |
| **Liabilities and Shareholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $85994 | $66095 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 222434 | 141904 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 7964 | 18367 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 316392 | 226366 |
| &nbsp;&nbsp;&nbsp;Long-term debt | 480631 | 318531 |
| &nbsp;&nbsp;&nbsp;Other noncurrent liabilities | 140764 | 138830 |
| &nbsp;&nbsp;&nbsp;Deferred taxes and other liabilities | 18800 | 16022 |
| &nbsp;&nbsp;&nbsp;Total liabilities | 956587 | 699749 |
| Commitments and Contingencies (Note 17) |  |  |
| **Shareholders' Equity:** |  |  |
| &nbsp;&nbsp;Preferred stock, par value $5.00 per share; authorized 2,000,000 shares; none issued |  |  |
| &nbsp;&nbsp;Class A Common Stock, par value $0.001 per share; authorized 100,000,000 shares; 40,989,106 issued in 2025 and 40,917,539 in 2024 | 41 | 41 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | 460294 | 452933 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 970435 | 1065763 |
| &nbsp;&nbsp;&nbsp;Accumulated items of other comprehensive income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Translation adjustments | (123189) | (181555) |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement liability adjustments | (17372) | (14328) |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative valuation adjustment | (737) | (106) |
| &nbsp;&nbsp;Treasury stock (Class A), at cost; 12,325,515 shares in 2025 and 9,844,746 in 2024 | (550174) | (379210) |
| &nbsp;&nbsp;&nbsp;Total shareholders' equity | 739298 | 943538 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interest | 5709 | 5409 |
| &nbsp;&nbsp;&nbsp;Total equity | 745007 | 948947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $1701594 | $1648696 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

**ALBANY INTERNATIONAL CORP.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in thousands)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| Net income/(loss) | $(70957) | $70310 |
| Adjustments to reconcile net income/(loss) to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 61577 | 61813 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 3903 | 5190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in deferred taxes and other liabilities | (21864) | (7552) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment | (390) | 1425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest expense | 777 | 769 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract loss provision | 139665 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits paid or payable in Class A Common Stock | 9882 | 4438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision/(recovery) for credit losses from uncollected receivables and contract assets | 553 | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency remeasurement loss/(gain) on intercompany loans | 7587 | 2263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fair value adjustment on foreign currency contracts |  | 1105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets | (1566) | (515) |
| Changes in operating assets and liabilities that provided/(used) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 2152 | 17980 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract assets | (7952) | (15194) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (5105) | 5918 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (3286) | 2768 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes prepaid and receivable | (13825) | 2602 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 18684 | 7316 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (22887) | (8320) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | (13022) | (11995) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent liabilities | (4307) | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (847) | (359) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 78772 | 139985 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (47559) | (61985) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchased software | (1250) | (101) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds received from sale of assets | 3243 | 1033 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (45566) | (61053) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowings | 231999 | 48106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of borrowings | (82044) | (142691) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of Treasury shares | (170964) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes paid in lieu of share issuance | (2521) | (2832) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | (24738) | (24356) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (48268) | (121773) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash and cash equivalents | 8089 | (3357) |
| Decrease in cash and cash equivalents | (6973) | (46198) |
| Cash and cash equivalents at beginning of period | 115283 | 173420 |
| Cash and cash equivalents at end of period | $108310 | $127222 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

**ALBANY INTERNATIONAL CORP.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(unaudited)**

***1. Significant Accounting Policies***

***Basis of Presentation***

In the opinion of management, the accompanying consolidated financial information reflects all adjustments necessary for a fair presentation of Albany International Corp.'s ("Albany", the "Registrant", the "Company", "we", "us", or "our") financial position, results of operations and cash flows for the interim periods presented, but does not include all disclosures required by the accounting principles generally accepted in the United States ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

***Estimates***

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used in the accounting for, among others, revenue recognition, contract profitability, allowances for doubtful accounts, rebates and sales allowances, inventory allowances, financial instruments, including derivatives, pension and other postretirement benefits, stock-based compensation, goodwill and intangible assets, contingencies, income taxes, and other accruals. Our estimates are based on historical experience and on various other assumptions, which are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ from those estimates. Estimates and assumptions are reviewed periodically, and the effects of any revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.

***Recent Accounting Pronouncements***

In September 2025, the Financial Accounting Standards Board (FASB) issued guidance to improve the accounting for costs related to internal-use software. The new guidance eliminates project stages and requires capitalizing software costs to begin when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. Additionally, disclosures for property, plant and equipment will be required for all capitalized software costs. The guidance is effective in the first quarter of 2028 with early adoption permitted as of the beginning of an annual reporting period. Upon adoption, the guidance may be applied prospectively, retrospectively or using a modified transition approach. We are evaluating the impact of this guidance on our consolidated financial statements.

In November 2024, the FASB issued guidance to improve the disclosure of expenses in commonly presented expense captions. The new guidance requires a public entity to provide tabular disclosure, on an annual and interim basis, of amounts for the following expense categories: (1) purchases of inventory, (2) employee compensation, (3) depreciation and (4) intangible asset amortization, as included in each relevant expense caption. Additionally, on an annual and interim basis, a qualitative description is required for amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. A relevant expense caption is an expense caption presented on the face of the income statement that contains any of the expense categories noted. The guidance also requires certain amounts that are currently required to be disclosed to be included in the same tabular disclosure as these disaggregation requirements. Furthermore, on an annual and interim basis, a public entity is required to separately disclose selling expenses and annually, disclose a description of the selling expenses. The guidance is effective for 2027 annual reporting, and in the first quarter of 2028 for interim reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We are evaluating the impact of this guidance on our consolidated financial statements.

In December 2023, the FASB issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit)

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. The guidance is effective for fiscal year 2025 annual reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted.

***2. Reportable Segments***

The Company is organized based on the nature of its products and is composed of two reportable segments, Machine Clothing ("MC") and Albany Engineered Composites ("AEC"), each overseen by a segment president. These segments are reflective of how the Company's Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purpose of allocating resources and assessing performance. Our CODM evaluates each segment's performance based on metrics such as net revenues, gross profit, and other key financial data, to assess performance and allocate resources that align with company-wide goals. The Company has not aggregated operating segments for purposes of identifying reportable segments. Effective December 31, 2024, the Company adopted provisions of ASU 2023-07, which expanded the content and frequency of segment disclosures required under ASC 280.

***Machine Clothing:***

The Machine Clothing segment supplies permeable and impermeable belts used in the manufacture of paper, paperboard, tissue and towel products, nonwovens, fiber cement and for several other industrial applications. We sell our MC products directly to customer end-users in countries across the globe. Our products, manufacturing processes, and distribution channels are substantially the same in each region of the world in which we operate.

We design, manufacture, and market paper machine clothing (used in the manufacture of paper, paperboard, tissue and towel) for each section of the paper machine and for every grade of paper. Paper machine clothing products are customized, consumable products of technologically sophisticated design that utilize polymeric materials in a complex structure.

***Albany Engineered Composites:***

The Albany Engineered Composites segment provides highly engineered, advanced composite structures to customers in the commercial and defense aerospace industries. The segment includes Albany Safran Composites, LLC ("ASC"), in which our customer, the SAFRAN Group ("SAFRAN") owns a 10 percent noncontrolling interest. AEC, through ASC, is the exclusive supplier to the LEAP program of advanced composite fan blades and fan cases under a long-term supply contract, where revenue is determined by a cost-plus-fee agreement.

Other significant programs for AEC include the Sikorsky CH-53K, F-35, JASSM, and Boeing 787 programs. AEC also supplies vacuum waste tanks for the Boeing commercial programs, and specialty components for the Rolls Royce lift fan on the F-35, as well as the fan case for the GE9X engine. For the year ended December 31, 2024, approximately 36 percent of AEC's revenues were related to U.S. government contracts or programs.

The following tables show data by reportable segment that is regularly provided to the CODM, reconciled to consolidated totals included in the financial statements along with other segment data:

**Reconciliation of Net Revenues to Operating Income(loss):**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>**(in thousands)** | **MC** | **AEC** | **Corporate** | **Total** |
| **Net revenues** | $**174950** | $**86484** | $**—** | $**261434** |
| Cost of goods sold | **92880** | **218492** | **—** | **311372** |
| **Gross profit** | **82070** | **(132008)** | **—** | **(49938)** |
| Selling, general and administrative expenses | **30291** | **12218** | **9396** | **51905** |
| Technical and research expenses | **6716** | **3673** | **1078** | **11467** |
| Restructuring expenses, net | **1960** | **113** | **1124** | **3197** |
| **Operating income/(loss)** | $**43103** | $**(148012)** | $**(11598)** | $**(116507)** |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>**(in thousands)** | **MC** | **AEC** | **Corporate** | **Total** |
| **Net revenues** | $183033 | $115353 | $— | $298386 |
| Cost of goods sold | 94112 | 113890 |  | 208002 |
| **Gross profit** | 88921 | 1463 |  | 90384 |
| Selling, general and administrative expenses | 32048 | 11923 | 8126 | 52097 |
| Technical and research expenses | 7042 | 3802 |  | 10844 |
| Restructuring expenses, net | 2207 | 34 | 31 | 2272 |
| **Operating income/(loss)** | $47624 | $(14296) | $(8157) | $25171 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>**(in thousands)** | **MC** | **AEC** | **Corporate** | **Total** |
| **Net revenues** | $**530573** | $**331034** | $**—** | $**861607** |
| Cost of goods sold | **284842** | **432710** | **—** | **717552** |
| **Gross profit** | **245731** | **(101676)** | **—** | **144055** |
| Selling, general and administrative expenses | **98841** | **34121** | **31257** | **164219** |
| Technical and research expenses | **21332** | **11472** | **3111** | **35915** |
| Restructuring expenses, net | **6322** | **1801** | **1772** | **9895** |
| **Operating income/(loss)** | $**119236** | $**(149070)** | $**(36140)** | $**(65974)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>**(in thousands)** | **MC** | **AEC** | **Corporate** | **Total** |
| **Net revenues** | $561828 | $381882 | $— | $943710 |
| Cost of goods sold | 299379 | 332878 |  | 632257 |
| **Gross profit** | 262449 | 49004 |  | 311453 |
| Selling, general and administrative expenses | 95384 | 36249 | 30814 | 162447 |
| Technical and research expenses | 22066 | 13303 |  | 35369 |
| Restructuring expenses, net | 3294 | 3144 | 146 | 6584 |
| **Operating income/(loss)** | $141705 | $(3692) | $(30960) | $107053 |

---

**Schedule of Depreciation and Amortization Expenses:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| **Depreciation and amortization** |  |  |  |  |
| Machine Clothing | $**8604** | $**8429** | $**24283** | $**25438** |
| Albany Engineered Composites | **13479** | **13596** | **40229** | **40700** |
| Corporate | **355** | **285** | **968** | **865** |
| Consolidated depreciation and amortization | $**22438** | $**22310** | $**65480** | $**67003** |

---

**Reconciliation of Operating Income/(loss) to Income before income taxes:**

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| **Operating income/(loss)** |  |  |  |  |
| Machine Clothing | $**43103** | $47624 | $**119236** | $141705 |
| Albany Engineered Composites | **(148012)** | (14296) | **(149070)** | (3692) |
| Corporate | **(11598)** | (8157) | **(36140)** | (30960) |
| Consolidated Operating income/(loss) | $**(116507)** | $25171 | $**(65974)** | $107053 |
| Reconciling items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest income/(loss) | **(1114)** | (1019) | **(4157)** | (3101) |
| &nbsp;&nbsp;Interest expense | **7011** | 3430 | **18859** | 11781 |
| &nbsp;&nbsp;&nbsp;Other (income)/expense, net | **(347)** | 3257 | **4170** | 5932 |
| Income/(loss) before income taxes | $**(122057)** | $19503 | $**(84846)** | $92441 |

---

Certain prior year amounts have been reclassified in order to conform to current year presentation. Global information system costs previously included in Corporate expenses are allocated to the segments. Management believes this presentation better reflects the performance of the segments and is how management will review segment performance on a going forward basis. For the three months ended September 30, 2025, Selling, general and administrative expenses include global information system costs of $4.9 million and $5.2 million for MC and AEC, respectively. For the three months ended September 30, 2024, Selling, general and administrative expenses include global information system costs of $3.9 million and $4.0 million for MC and AEC, respectively. For the nine months ended September 30, 2025, Selling, general and administrative expenses include global information system costs of $12.8 million and $13.0 million for MC and AEC, respectively. For the nine months ended September 30, 2024, Selling, general and administrative expenses include global information system costs of $11.6 million and $12.0 million for MC and AEC, respectively.

The following table presents assets by reportable segment:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| **Segment assets** | | |
| Machine Clothing | $**625460** | $600603 |
| Albany Engineered Composites | **726588** | 736306 |
| Reconciling items: |  |  |
| &nbsp;&nbsp;Cash | **108310** | 115283 |
| &nbsp;&nbsp;Income taxes prepaid and receivable, and Deferred income taxes | **90273** | 47944 |
| &nbsp;&nbsp;Prepaid expenses and other current assets, and Other assets | **150963** | 148560 |
| Consolidated total assets | $**1701594** | $1648696 |

---

The following table presents capital expenditures by reportable segment:

---

| | | |
|:---|:---|:---|
| | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** |
| **Capital expenditures and purchased software** |  |  |
| Machine Clothing | $**20387** | $17184 |
| Albany Engineered Composites | **28422** | 44902 |
| Total capital expenditures and purchased software | $**48809** | $62086 |

---

***3. Revenue Recognition:***

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

Products and services provided under long-term contracts represent a significant portion of revenues in the Albany Engineered Composites segment and we account for these contracts over time, primarily using the percentage of completion (actual cost to estimated cost) method. That method requires significant judgment and estimation, which could be materially different if the underlying circumstances were to change. When adjustments in estimated contract revenues or costs are required, any changes from prior estimates are included in earnings in the period the change occurs.

The LEAP engine is used on the Airbus A320neo, A321neo, Boeing 737 MAX, and COMAC 919 aircraft. AEC's largest aerospace customer is the SAFRAN Group and sales to SAFRAN (consisting primarily of fan blades and cases for CFM International's LEAP engine) were $46.4 million and $40.9 million for the three months ended September 30, 2025 and 2024, respectively and $130.2 million and $142.2 million in the first nine months of 2025 and 2024, respectively. The total of Accounts receivable, Contract assets and Noncurrent receivables due from SAFRAN amounted to $67.6 million and $78.5 million as of September 30, 2025 and December 31, 2024, respectively.

Changes in the estimated profitability of long-term contracts could be caused by increases or decreases in the contract value, revisions to customer delivery requirements, updated labor or overhead projections, material costs, factors affecting the supply chain, changes in the evaluation of contract risks and opportunities, or other factors. The cumulative changes in the estimated profitability of long-term contracts decreased revenue by $49.1 million and operating income by $150.9 million during the third quarter of 2025. Adjustments to the estimated profitability of long-term contracts decreased revenue by $67.6 million and operating income by $165.1 million for the first nine months of 2025. The decrease in profitability during the third quarter of 2025 was primarily driven by a few large complex programs, including adjustments of $147.3 million for various CH-53K programs, based on changes to material input costs, labor hours, and future overhead rates over the remainder of the contract. Additionally, we recorded negative cumulative changes in profitability of $0.2 million on our F-35 program, $0.9 million on our Gulfstream program and $2.6 million, net on all other programs. The negative cumulative change in profitability during the nine months ended September 30, 2025 was driven by $157.4 million for various CH-53K programs, $2.3 million on our F-35 program, and $5.5 million, net on all other programs. Adjustments in the estimated profitability of long-term contracts decreased operating income by $22.4 million during the third quarter of 2024 and $28.3 million for the first nine months of 2024.

We disaggregate revenue earned from contracts with customers for each of our business segments and product groups based on the timing of revenue recognition, and groupings used for internal review purposes.

The following table disaggregates revenue for each product group by timing of revenue recognition for the three months ended September 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** |
|<br>**(in thousands)** | **Point in Time Revenue**<br>**Recognition** | **Over Time Revenue**<br>**Recognition** | **Total** |
| Machine Clothing | $**173929** | $**1021** | $**174950** |
| Albany Engineered Composites: |  |  |  |
| ASC | **—** | **44873** | **44873** |
| Other AEC | **3084** | **38527** | **41611** |
| Total Albany Engineered Composites | $**3084** | $**83400** | $**86484** |
| Total revenues | $**177013** | $**84421** | $**261434** |

---

The following table disaggregates revenue for each product group by timing of revenue recognition for the three months ended September 30, 2024:

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** |
|<br>**(in thousands)** | **Point in Time Revenue**<br>**Recognition** | **Over Time Revenue**<br>**Recognition** | **Total** |
| Machine Clothing | $182050 | $983 | $183033 |
| Albany Engineered Composites: |  |  |  |
| ASC |  | 40115 | 40115 |
| Other AEC | 4142 | 71096 | 75238 |
| Total Albany Engineered Composites | $4142 | $111211 | $115353 |
| Total revenues | $186192 | $112194 | $298386 |

---

The following table disaggregates revenue for each product group by timing of revenue recognition for the nine months ended September 30, 2025

---

| | | | |
|:---|:---|:---|:---|
| | **Nine months ended September 30, 2025** | **Nine months ended September 30, 2025** | **Nine months ended September 30, 2025** |
| **(in thousands)** | **Point in Time Revenue<br>Recognition** | **Over Time Revenue<br>Recognition** | **Total** |
| Machine Clothing | $**527509** | $**3064** | $**530573** |
| Albany Engineered Composites: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ASC | **—** | **128639** | **128639** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other AEC | **10221** | **192174** | **202395** |
| Total Albany Engineered Composites | $**10221** | $**320813** | $**331034** |
| Total revenues | $**537730** | $**323877** | $**861607** |

---

The following table disaggregates revenue for each product group by timing of revenue recognition for the nine months ended September 30, 2024

---

| | | | |
|:---|:---|:---|:---|
| | **Nine months ended September 30, 2024** | **Nine months ended September 30, 2024** | **Nine months ended September 30, 2024** |
| **(in thousands)** | **Point in Time Revenue<br>Recognition** | **Over Time Revenue<br>Recognition** | **Total** |
| Machine Clothing | $558881 | $2947 | $561828 |
| Albany Engineered Composites: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ASC |  | 140146 | 140146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other AEC | 15908 | 225828 | 241736 |
| Total Albany Engineered Composites | $15908 | $365974 | $381882 |
| Total revenues | $574789 | $368921 | $943710 |

---

The following table disaggregates MC segment revenue by significant product groupings (paper machine clothing ("PMC") and engineered fabrics); and for PMC, the geographical region to which the paper machine clothing was sold:

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Americas PMC | $**92171** | $86408 | $**262505** | $258442 |
| Eurasia PMC | **67128** | 70083 | **206486** | 224792 |
| Engineered Fabrics | **15651** | 26542 | **61582** | 78594 |
| Total Machine Clothing Net revenues | $**174950** | $183033 | $**530573** | $561828 |

---

We do not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less. Contracts in the MC segment are generally for periods of less than a year and certain contracts in the AEC segment are relatively short duration firm-fixed-price orders. Remaining performance obligations on contracts that had an original duration of greater than one year totaled $1.1 billion and $1.1 billion as of September 30, 2025 and 2024, respectively, and related primarily to firm fixed price contracts in the AEC segment. Of the remaining performance obligations as of September 30, 2025, we expect to recognize as revenue approximately $51.0 million during 2025, $182.1 million during 2026, $165.5 million during 2027, and the remainder thereafter.

***4. Pensions and Other Postretirement Benefit Plans***

The Company has defined benefit pension plans covering certain U.S. and non-U.S. employees. The Company also provides certain postretirement benefits to retired employees in the U.S. and Canada. The Company accrues the cost of providing these benefits during the active service period of the employees.

The composition of the net periodic benefit cost/(income) for the nine months ended September 30, 2025 and 2024, was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension plans** | **Pension plans** | **Other postretirement benefits** | **Other postretirement benefits** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Components of net periodic benefit cost/(income): |  |  |  |  |
| Service cost | $**836** | $1473 | $**30** | $35 |
| Interest cost | **4505** | 4545 | **1060** | 1063 |
| Expected return on assets | **(3427)** | (4030) | **—** |  |
| Curtailment cost/(income) | **(3770)** |  | **—** |  |
| Settlement cost/(income) | **2170** |  | **—** |  |
| Amortization of prior service cost/(income) | **(20)** | (20) | **(92)** | (93) |
| Amortization of net actuarial loss | **932** | 556 | **(24)** | (26) |
| Net periodic benefit cost/(credit) | $**1226** | $2524 | $**974** | $979 |

---

The amount of net benefit cost/(credit) is determined at the beginning of each year and generally only varies from quarter to quarter when a significant event occurs, such as a curtailment or a settlement. In the first nine months of 2025, we took action to settle certain pension plan liabilities related to an MC pension plan in Switzerland, resulting in a net gain totaling $1.6 million related to curtailments and settlements. There were no material curtailments or settlements during the nine months ended September 30, 2024.

Service cost for defined benefit pension and postretirement plans are reported in the same line item as other compensation costs arising from services rendered by the pertinent employees during the period. Other components of net periodic benefit cost are included in the line item Other (income)/expense, net in the Consolidated Statements of Income.

***5. Restructuring***

At MC, restructuring actions were taken in 2025 and 2024 to cease operations at five facilities.

For the three months ended September 30, 2025, these actions related to workforce reductions of $2.0 million. For the three month ended September 30, 2024, these actions related to workforce reductions and inventory write-off costs totaling $2.2 million.

For the nine months ended September 30, 2025, these actions related to workforce reductions, fixed asset impairments and related costs and inventory write-off costs of $8.1 million offset by a $1.8 million pension curtailment

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

gain. For the nine months ended September 30, 2024 these actions related to workforce reductions of $3.3 million, as well as charges of $1.3 million in costs of goods sold for the write-off of inventory.

At AEC, restructuring activities were related to reorganizational and workforce reduction costs, which resulted in restructuring expenses of $0.1 million for the three months ended September 30, 2025 and $0.0 million for the three months ended September 30, 2024. For the nine months ended September 30, 2025 and September 30, 2024, restructuring expenses were related to reductions in workforce and totaled $1.8 million and $3.1 million, respectively.

The following table summarizes charges reported in the Consolidated Statements of Income under "Restructuring expenses, net":

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Machine Clothing | $**1960** | $2207 | $**6322** | $3294 |
| Albany Engineered Composites | **113** | 34 | **1801** | 3144 |
| Corporate expenses | **1124** | 31 | **1772** | 146 |
| Total | $**3197** | $2272 | $**9895** | $6584 |

---

The following tables summarize charges by type of expense reported in the Consolidated Statements of Income under "Restructuring expenses, net" and "Cost of goods sold":

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nine months ended September 30, 2025**<br>**(in thousands)** | **Total<br>restructuring<br>costs incurred** | **Termination<br>and other<br>costs** | **Impairment of assets** | **Pension Curtailment (Gain)/Loss** |
| Machine Clothing | $**6322** | $**7359** | $**723** | $**(1760)** |
| Albany Engineered Composites | **1801** | **1801** | **—** | **—** |
| Corporate expenses | **1772** | **1772** | **—** | **—** |
| Total | $**9895** | $**10932** | $**723** | $**(1760)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nine months ended September 30, 2024**<br>**(in thousands)** | **Total<br>restructuring<br>costs incurred** | **Termination<br>and other<br>costs** | **Impairment of assets** | **Pension Curtailment (Gain)/Loss**<br> |
| Machine Clothing | $4581 | $3294 | $1287 | $— |
| Albany Engineered Composites | 3144 | 3144 |  |  |
| Corporate expenses | 146 | 146 |  |  |
| Total | $7871 | $6584 | $1287 | $— |

---

The table below presents the year-to-date changes in restructuring liabilities for 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **December 31, 2024** | **Restructuring<br>charges accrued** | **Payments and other** | **September 30, 2025** |
| Total restructuring and other liabilities | $**4996** | $**10932** | $**(12622)** | $**3306** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **December 31, 2023** | **Restructuring<br>charges accrued** | **Payments and other** | **September 30, 2024** |
| Total restructuring and other liabilities | $– $| 7871 | $(3974) | $3897 |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

***6. Other (Income)/Expense, net***

The components of Other (income)/expense, net are:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Currency transaction losses/(gains) | $**(1054)** | $1834 | $**7751** | $692 |
| Derivative instruments losses/(gains) | **(95)** | (485) | **(3357)** | 3788 |
| Components of net periodic pension and postretirement cost other than service cost | **1011** | 663 | **1334** | 1995 |
| Other losses/(gains) | **(209)** | 1245 | **(1558)** | (543) |
| Total other (income)/expense, net | $**(347)** | $3257 | $**4170** | $**5932** |

---

Currency transaction losses/(gains), included within other (income)/expense, net were primarily the result of both realized and unrealized losses/(gains) on intercompany loans. In addition, changes in the fair value of derivative instruments included gains driven by currency rate movements, most notably the Brazilian Real and Mexican Peso. The Company divested its Arcari business during the quarter ended June 30, 2025, resulting in a net gain of $1.6 million, which is included within other (income)/expense, net for the nine months ended September 30, 2025.

***7. Income Taxes***

The Company's effective income tax rate for the three and nine months ended September 30, 2025 and 2024, is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Effective income tax rate | **20.0%** | 6.6% | **16.4%** | 23.9% |

---

Income tax expense for the quarter was computed in accordance with ASC 740-270, Income Taxes – Interim Reporting. Under this method, loss jurisdictions subject to valuation allowances cannot recognize a tax benefit with regard to their generated losses and are excluded from the annual effective tax rate calculation as their taxes will be recorded discretely in each quarter.

Our 2025 estimated annual effective tax rate primarily reflects the 21% federal tax rate, the impact of state and local taxation, the impact of taxation upon foreign operations, and forecasted permanent differences. Our actual effective tax rates were 20.0% and 6.6% for the three months ended September 30, 2025 and 2024, respectively. Our actual effective tax rates were 16.4% and 23.9% for the nine months ended September 30, 2025 and 2024, respectively.

The effective tax rate for the three months ended September 30, 2025 included a net discrete tax benefit of $0.7 million. This discrete tax benefit is mostly attributable to the true-up for prior year's estimated taxes. The rate for the three months ended September 30, 2025 was higher than the three months ended September 30, 2024 mainly due to a significant favorable discrete tax adjustment in the quarter ended September 30, 2024 related to the decrease in the valuation allowance as compared to the current period.

The effective tax rate for the nine months ended September 30, 2025 included a net discrete tax benefit of $2.3 million. The discrete tax benefit recognized primarily reflects adjustments to prior year estimated tax provisions to actual filings, a net reduction in valuation allowances, and a net decrease in uncertain tax positions. The effective rate for the nine months ended September 30, 2025 was lower than the nine months ended September 30, 2024, largely due to the favorable impact of discrete tax items, including the release of valuation allowances in the current period.

The Company is subject to audit in the U.S. and various foreign jurisdictions. Our open tax years for major jurisdictions generally range from 2013-2024. We believe appropriate provisions for all outstanding tax issues have been made for all jurisdictions and all open years. Audit outcomes and the timing of audit settlements are subject to significant uncertainty. It is reasonably possible that within the next 12 months, unrecognized tax benefits could decrease by up to $2.1 million based on current estimates.

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

***8. Earnings Per Share***

The amounts used in computing earnings per share and the weighted average number of shares of potentially dilutive securities are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands, except earnings per share)** | **2025** | **2024** | **2025** | **2024** |
| Net income/(loss) attributable to the Company | $**(97760)** | $18029 | $**(71222)** | $69944 |
| **Weighted average number of shares:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Weighted average number of shares used in calculating basic net income/(loss) per share | **29012** | 31251 | **29914** | 31234 |
| **Effect of dilutive stock-based compensation plans:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Restricted stock units and multi-year awards | **—** | 116 | **—** | 99 |
| &nbsp;&nbsp;&nbsp;Weighted average number of shares used in calculating diluted net income/(loss) per share | **29012** | 31367 | **29914** | 31333 |

---

For the three and nine months ended September 30, 2025, basic and diluted shares outstanding are equal as a result of the Company's net loss and potentially dilutive shares being anti-dilutive.

***9. Accumulated Other Comprehensive Income ("AOCI")***

The table below presents changes in the components of AOCI for the period from December 31, 2024 to September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **Translation**<br>**adjustments** | **Pension and**<br>**postretirement**<br>**liability**<br>**adjustments** | **Derivative**<br>**valuation**<br>**adjustment** | **Total Accumulated Other<br>Comprehensive<br>Income/(Loss)** |
| **December 31, 2024** | $**(181555)** | $**(14328)** | $**(106)** | $**(195989)** |
| Foreign currency translation and other adjustments | 58366 | (2418) | (358) | 55590 |
| Pension settlement/curtailment, net of tax |  | (1178) |  | (1178) |
| Interest (expense)/income related to swaps reclassified to the Consolidated Statements of Income/(Loss), net of tax |  |  | (273) | (273) |
| Pension and postretirement liability adjustments reclassified to Consolidated Statements of Income/(Loss), net of tax |  | 552 |  | 552 |
| Net current period other comprehensive income/(loss) | 58366 | (3044) | (631) | 54691 |
| **September 30, 2025** | $**(123189)** | $**(17372)** | $**(737)** | $**(141298)** |

---

The table below presents changes in the components of AOCI for the period from December 31, 2023 to September 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in thousands)** | **Translation**<br>**adjustments** | **Pension and**<br>**postretirement**<br>**liability**<br>**adjustments** | **Derivative**<br>**valuation**<br>**adjustment** | **Total Accumulated Other<br>Comprehensive<br>Income/(Loss)** |
| **December 31, 2023** | $**(124901)** | $**(17346)** | $**9079** | $**(133168)** |
| Foreign currency translation and other adjustments | (12472) | (285) | 298 | (12459) |
| Interest (expense)/income related to swaps reclassified to the Consolidated Statements of Income/(Loss), net of tax |  |  | (8212) | (8212) |
| Pension and postretirement liability adjustments reclassified to Consolidated Statements of Income/(Loss), net of tax |  | 290 |  | 290 |
| Net current period other comprehensive income/(loss) | (12472) | 5 | (7914) | (20381) |
| **September 30, 2024** | $**(137373)** | $**(17341)** | $**1165** | $**(153549)** |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

The components of AOCI that are reclassified to the Consolidated Statements of Income/(Loss) relate to our pension and postretirement plans and interest rate swaps.

The table below presents the expense/(income) amounts reclassified from AOCI, and the line items of the Consolidated Statements of Income/(Loss) that were affected for the three and nine months ended September 30, 2025, and the Consolidated Statements of Income/(Loss) for the three and nine months ended September 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| **Pre-tax Derivative valuation reclassified from Accumulated Other Comprehensive Income/(Loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest (income)/expense, net related to interest rate swaps included in Income/(loss) before taxes | $**(53)** | $(2675) | $**(324)** | $(10893) |
| &nbsp;&nbsp;&nbsp;Income tax effect | **17** | 658 | **51** | 2681 |
| Effect on net income due to items reclassified from Accumulated Other Comprehensive Income/(Loss) | $**(36)** | $(2017) | $**(273)** | $(8212) |
| **Pre-tax pension and postretirement liabilities reclassified from Accumulated Other Comprehensive Income:** |  |  |  |  |
| &nbsp;&nbsp;Pension settlement/curtailment | $**—** | $— | $**(1600)** | $0 |
| &nbsp;&nbsp;&nbsp;Amortization of prior service credit | $**(38)** | $(37) | $**(112)** | $(113) |
| &nbsp;&nbsp;Amortization of net actuarial loss | **315** | 176 | **908** | 530 |
| Total pre-tax amount reclassified | **277** | 139 | **(804)** | 417 |
| &nbsp;&nbsp;&nbsp;Income tax effect | **(86)** | (42) | **178** | (127) |
| Effect on net income due to items reclassified from Accumulated Other Comprehensive Income | $**191** | $97 | $**(626)** | $290 |

---

***10. Noncontrolling Interests***

Effective October 31, 2013, Safran S.A. (Safran) acquired a 10 percent equity interest in Albany Safran Composites, LLC ("ASC").

On August 31, 2023, the Company acquired all the outstanding shares of Heimbach, a privately held manufacturer of paper machine clothing with headquarters in Düren, Germany. In July 2021, Heimbach acquired 85% of Arcari, SRL ("Arcari"). Arcari is a manufacturer of textile and plastic industrial technical products and conveyor belts.

On April 1, 2025, Heimbach sold its 85% controlling interest in Arcari to the minority shareholder and recorded a gain of $1.6 million included in Other (Income) expense on the sale. In connection with the sale, the corresponding value of the non-controlling interest was reduced to zero. The Company did not retain any ownership in Arcari as a result of the sale and accordingly there was no impact on operating results during the third quarter of 2025.

The table below presents a reconciliation of income attributable to the noncontrolling interest and noncontrolling equity in the Company's subsidiaries:

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | |
|:---|:---|:---|
| **ASC Noncontrolling Interest** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** |
| Net income of Albany Safran Composites (ASC) | $**4857** | $3754 |
| Less: Return attributable to the Company's preferred holding | **1352** | 850 |
| Net income of ASC available for common ownership | $**3505** | $2904 |
| Ownership percentage of noncontrolling shareholder | **10%** | 10% |
| Net income attributable to the noncontrolling interest | $**351** | $290 |
| Noncontrolling interest, beginning of year | $**4983** | $5423 |
| Net income attributable to noncontrolling interest | **351** | 290 |
| Changes in other comprehensive income attributable to the noncontrolling interest | **376** | (481) |
| ASC Noncontrolling interest, end of interim period | $**5709** | $5232 |
| Arcari Noncontrolling interest, end of interim period | $**0** | $447 |
| **Total Noncontrolling interest, end of interim period** | $**5709** | $5679 |

---

***11. Accounts Receivable***

Accounts receivable, net includes trade and other accounts receivable and bank promissory notes, net of allowance for expected credit losses. In connection with certain revenues in Asia, the Company accepts a bank promissory note as customer payment. The notes may be presented for payment at maturity, which is less than one year. As of September 30, 2025 and December 31, 2024, Accounts receivable consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Trade and other accounts receivable | $**243303** | $231136 |
| Bank promissory notes | **20218** | 19637 |
| Allowance for expected credit losses | **(5018)** | (4085) |
| Accounts receivable, net | $**258503** | $246688 |

---

As of September 30, 2025 and December 31, 2024, the Company had trade accounts receivable from SAFRAN of $67.1 million and $77.7 million, respectively.

***12. Contract Assets and Liabilities***

Contract assets include unbilled amounts typically resulting from revenues under contracts when the over time method of revenue recognition is utilized, and revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to Accounts receivable, net when the entitlement to pay becomes unconditional and the customer is invoiced. Contract liabilities include advance payments and billings in excess of revenue recognized. Contract liabilities are included in Accrued liabilities in the Consolidated Balance Sheets.

Contract assets and Contract liabilities are reported on the Consolidated Balance Sheets in a net position on a contract-by-contract basis at the end of each reporting period.

As of September 30, 2025 and December 31, 2024, Contract assets and Contract liabilities consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Contract assets | $**140996** | $167397 |
| Allowance for expected credit losses | **(737)** | (840) |
| Contract assets, net | $**140259** | $166557 |
| Contract liabilities | $**9802** | $6085 |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

Contract assets, net decreased $26.3 million during the nine months ended September 30, 2025, primarily due to a decrease in unbilled revenue related to commercial and defense programs. There were no impairment losses related to our Contract assets during the nine months ended September 30, 2025 and September 30, 2024.

Contract liabilities increased $3.7 million for the period ended September 30, 2025 compared to December 31, 2024, primarily due to the amounts invoiced to customers for contracts that were in a contract liability position exceeding the revenue recognized from satisfied performance obligations. Revenue recognized for the nine months ended September 30, 2025 and 2024 that was included in the Contract liability balance at the beginning of the year was $5.6 million and $3.7 million, respectively.

***13. Inventories***

Costs included in inventories are raw materials, labor, supplies and allocable depreciation and overhead. Raw material inventories are valued on an average cost basis. Other inventory cost elements are valued at cost, using the first-in, first-out method. The Company writes down the inventories for estimated obsolescence and to lower of cost or net realizable value based upon assumptions about future demand and market conditions. If actual demand or market conditions are less favorable than those projected by the Company, additional inventory write-downs may be required. Once established, the original cost of the inventory less the related write-down represents the new cost basis of such inventories.

As of September 30, 2025 and December 31, 2024, Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Raw materials | $**85364** | $76559 |
| Work in process | **58313** | 54917 |
| Finished goods | **15987** | 14369 |
| Total inventories | $**159664** | $145845 |

---

***14. Goodwill and Other Intangible Assets***

The following table sets forth the gross carrying value, accumulated amortization and net values of intangible assets and goodwill as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| **(in thousands)** | **Amortization <br>life in years** | **Gross carrying amount** | **Accumulated amortization and other** | **Net carrying amount** |
| **Finite-lived assets:** | | | | |
| AEC Trademarks and trade names | 6-15 | $**208** | $**(205)** | $**3** |
| AEC Technology | 10-15 | **6528** | **(3962)** | **2566** |
| AEC Intellectual property | 15 | **1250** | **(485)** | **765** |
| AEC Customer relationships | 8-15 | **69559** | **(50069)** | **19490** |
| Heimbach Developed technology | 9 | **9281** | **(2461)** | **6820** |
| Total Finite-lived intangible assets |  | $**86826** | $**(57182)** | $**29644** |
| **Indefinite-lived intangible assets:** |  |  |  |  |
| Heimbach Trade name |  | $**6454** | $**—** | $**6454** |
| MC Goodwill |  | **69871** | **—** | **69871** |
| AEC Goodwill |  | **114420** | **—** | **114420** |
| Total Indefinite-lived intangible assets: |  | $**190745** | $**—** | $**190745** |

---

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| **(in thousands)** | **Amortization <br>life in years** | **Gross carrying amount** | **Accumulated amortization and other** | **Net carrying amount** |
| **Finite-lived assets:** | | | | |
| AEC Trademarks and trade names | 6-15 | $208 | $(197) | $11 |
| AEC Technology | 10-15 | 5820 | (3140) | 2680 |
| AEC Intellectual property | 15 | 1250 | (422) | 828 |
| AEC Customer relationships | 8-15 | 69175 | (47283) | 21892 |
| Heimbach Developed technology | 9 | 8547 | (1543) | 7004 |
| Total Finite-lived assets |  | $85000 | $(52585) | $32415 |
| **Indefinite-lived intangible assets:** |  |  |  |  |
| Heimbach Trade name |  | $5712 | $— | $5712 |
| MC Goodwill |  | 63988 |  | 63988 |
| AEC Goodwill |  | 112273 |  | 112273 |
| Total Indefinite-lived intangible assets: |  | $181973 | $— | $181973 |

---

The changes in intangible assets, net and goodwill from December 31, 2024 to September 30, 2025, were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in thousands)** | **December 31, 2024** | **Other<br>Changes** | **Amortization** | **Currency<br>Translation** | **September 30, 2025** |
| **Finite-lived intangible assets:** | | | | | |
| AEC Trademarks and trade names | $**11** | $**—** | $**(8)** | $**—** | $**3** |
| AEC Technology | **2680** | **—** | **(462)** | **348** | **2566** |
| AEC Intellectual property | **828** | **—** | **(63)** | **—** | **765** |
| AEC Customer relationships | **21892** | **—** | **(2626)** | **224** | **19490** |
| Heimbach Developed technology | **7004** | **(315)** | **(741)** | **872** | **6820** |
| Total Finite-lived intangible assets | $**32415** | $**(315)** | $**(3900)** | $**1444** | $**29644** |
| **Indefinite-lived intangible assets:** |  |  |  |  |  |
| Heimbach Trade name | $**5712** | $**—** | $**—** | $**742** | $**6454** |
| MC Goodwill | **63988** | **—** | **—** | **5883** | **69871** |
| AEC Goodwill | **112273** | **—** | **—** | **2147** | **114420** |
| Total Indefinite-lived assets: | $**181973** | $**—** | $**—** | $**8772** | $**190745** |

---

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in each business combination. Goodwill and intangible assets with indefinite useful lives are not amortized, but are tested for impairment at least annually.

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

***15. Financial Instruments***

The following table represents the Company's outstanding debt:

---

| | | |
|:---|:---|:---|
| **(in thousands, except interest rates)** | **September 30, 2025** | **December 31, 2024** |
| Borrowings under the Amended Credit Agreement |  |  |
| USD borrowings | $**375000** | $225000 |
| EUR borrowings | **105631** | 93485 |
| Foreign bank debt | **—** | 46 |
| Total bank debt | **480631** | 318531 |
| Less: Current maturities of long-term debt | **—** |  |
| Long-term debt | $**480631** | $318531 |

---

***Amended Credit Agreement***

On August 16, 2023, we entered into a $800 million unsecured committed Five-Year Revolving Credit Facility Agreement, amended on June 28, 2024 (collectively, the "Amended Credit Agreement"), which matures in August of 2028.

The applicable interest rate for borrowings under the Amended Credit Agreement is based on both Term SOFR and EURIBOR plus a spread, which is based on our leverage ratio (as defined in the Amended Credit Agreement) at the time of a borrowing as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Leverage Ratio** | **Commitment Fee** | **ABR Spread** | **Term Benchmark/ Daily<br>Simple SOFR Spread** |
| <1.00:1.00 | 0.275% | 0.500% | 1.500% |
| ≥ 1.00:1.00 and < 2.00:1.00 | 0.300% | 0.625% | 1.625% |
| ≥ 2.00:1.00 and < 3.00:1.00 | 0.325% | 0.750% | 1.750% |
| ≥ 3.00:1.00 | 0.350% | 1.000% | 2.000% |

---

As of September 30, 2025, the applicable interest rate for borrowings under the Amended Credit Agreement was based on one-month term SOFR and one-month EURIBOR plus the spread, which was 1.625%.

As of September 30, 2025, there was $480.6 million of borrowings outstanding under the Amended Credit Agreement and we had borrowings available of $319.4 million, based on our maximum leverage ratio and our Consolidated EBITDA (as defined in the Amended Credit Agreement).

At the end of September 30, 2025 and December 31, 2024, the USD interest rate in effect was 5.84% and 5.77%, respectively, including the effect of interest rate swaps; at the end of September 30, 2025 and December 31, 2024, the EUR interest rate in effect was 3.70% and 4.09%, respectively, including the effect of interest rate swaps.

Under the Amended Credit Agreement, we are required to maintain a leverage ratio (as defined in the Credit Agreement) of not greater than 3.75 to 1.00, or 4.25 to 1.00 after a significant acquisition. We are also required to maintain a minimum interest coverage ratio (as defined in the Credit Agreement) of greater than 3.00 to 1.00. If our leverage ratio exceeds 3.50 to 1.00, we will be restricted in paying dividends to a maximum amount of $40 million in a calendar year

As of September 30, 2025, our leverage ratio was 1.70 to 1.00 and our interest coverage ratio was 9.15 to 1.00. As of September 30, 2025, we were in compliance with all applicable covenants. We anticipate continued compliance in each of the next four quarters while continuing to monitor future compliance based on current and future economic conditions.

The borrowings are guaranteed by certain of the Company's subsidiaries, including all significant U.S. subsidiaries (subject to certain exceptions), as defined in the Amended Credit Agreement. Our ability to borrow additional amounts under the Amended Credit Agreement is conditional upon the absence of any defaults, as well as the absence of any material adverse change (as defined in the Amended Credit Agreement).

***Interest Rate Swaps***

From time to time, the Company enters into interest rate swap contracts to manage the interest rate risk associated with its outstanding variable-interest rate borrowings. Such contracts are intended to economically hedge the

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

reference rate component of future interest payments associated with outstanding borrowings under the Company's Amended Credit Agreement.

In November, 2024, we entered into two interest rate swap agreements: A USD interest rate swap agreement and a EUR interest rate swap agreement. The USD interest rate swap agreement covers the period November 15, 2024 through November 15, 2026. This transaction has the effect of fixing the SOFR portion of the interest rate (before the credit spread) on $125 million of the US indebtedness drawn under the Amended Credit Facility. Under the terms of this transaction, the Company pays a fixed rate of 3.987% and our counterparty pays a floating rate based on the one-month SOFR rate at each monthly calculation date. The EUR interest rate swap agreement covers the period November 14, 2024 through November 15, 2026. This transaction has the effect of fixing the EURIBOR portion of the interest rate (before the credit spread) on EUR 45 million of the EUR indebtedness drawn under the Amended Credit Facility. Under the terms of this transaction, the Company pays a fixed rate of 2.277% and our counterparty pays a floating rate based on the one-month EURIBOR rate at each monthly calculation date.

In 2021, we entered into interest rate swap agreements for the period of October 17, 2022 through October 27, 2024, to hedge $350 million of variable-interest rate indebtedness.

These interest rate swaps are accounted for as a hedge of future cash flows, as further described in *Note 16, Fair-Value Measurements*. No cash collateral was received or pledged in relation to the swap agreements.

***16. Fair-Value Measurements***

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 - Quoted prices in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 - Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

We had no Level 3 financial assets or liabilities at September 30, 2025 or at December 31, 2024, other than certain pension assets as indicated in our December 31, 2024 Annual Report on Form 10-K.

The following table presents the fair-value hierarchy for our Level 1 and Level 2 financial and non-financial assets and liabilities, which are measured at fair value on a recurring basis:

------

*<u>[Index](#i4ea757eceb924ec6b364a53fc8072a64_7)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|<br>**(in thousands)** | **Quoted**<br>**prices in**<br>**active**<br>**markets**<br>**(Level 1)** | **Significant**<br>**other**<br>**observable**<br>**inputs**<br>**(Level 2)** | **Quoted**<br>**prices in**<br>**active**<br>**markets**<br>**(Level 1)** | **Significant**<br>**other**<br>**observable**<br>**inputs**<br>**(Level 2)** |
| **Fair Value** | | | | |
| *Assets:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash equivalents | $**15440** | $— | $11273 | $— |
| &nbsp;&nbsp;Foreign currency option contracts  | **—** |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts | **—** |  |  |  |
| &nbsp;&nbsp;*Other Assets:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common stock of unaffiliated foreign public company (a) | **799** |  | 631 |  |
| &nbsp;&nbsp;&nbsp;Interest rate swaps |  |  |  | 149 |
| *Liabilities:* |  |  |  |  |
| *Other Non-Current Liabilities* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate swaps |  | **(905)** |  | (218) |

---

(a)Original cost basis $0.5 million.

Cash equivalents include short-term securities that are considered to be highly liquid and easily tradable. These securities are valued using inputs observable in active markets for identical securities.

The interest rate swaps are accounted for as hedges of future cash flows. The fair value of our interest rate swaps is derived from a discounted cash flow analysis based on the terms of the contract and the interest rate curve, and is included in Other assets and/or Other noncurrent liabilities in the Consolidated Balance Sheets. Unrealized gains and losses on the interest rate swaps are recorded as a component of Derivative valuation adjustment in the Shareholders' equity section of the Consolidated Balance Sheets. As of September 30, 2025, these interest rate swaps were determined to be highly effective hedges of interest rate cashflow risk. Amounts accumulated in Other comprehensive income are reclassified as interest expense/(income), net when the related interest payments (that is, the hedged forecasted transactions), affect earnings. Interest expense/(income) related to payments under the active swap agreements totaled $(0.3) million for the nine months ended September 30, 2025 and $(12.3) million for the nine months ended September 30, 2024.

We operate our business in many regions of the world, and currency rate movements can have a significant effect on operating results. From time to time, we enter into foreign currency option contracts and forward contracts that are valued using quoted prices in active markets obtained from independent pricing sources. These instruments are measured using market foreign exchange prices and are recorded in the Consolidated Balance Sheets as Other current assets and Accrued liabilities, as applicable. Changes in fair value of these instruments are recorded as gains or losses within Other (income)/expense, net.

When exercised, the foreign currency instruments are net-settled with the same financial institution that bought or sold them. For all positions, whether options or forward contracts, there is a risk from the possible inability of the financial institution to meet the terms of the contracts and the risk of unfavorable changes in interest and currency rates, which may reduce the value of the instruments. We seek to mitigate risk by evaluating the creditworthiness of counterparties and by monitoring the currency exchange and interest rate markets while reviewing the hedging risks and contracts to ensure compliance with our internal guidelines and policies.

(Gains)/losses related to changes in fair value of derivative instruments that were recognized in Other (income)/expense, net in the Consolidated Statements of Income were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** | **2025** | **2024** |
| Derivatives not designated as hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency options (gains)/losses | $**(95)** | $(485) | $**(3356)** | $3788 |

---

------

***17. Commitments and Contingencies***

**Asbestos Litigation**

Albany International Corp. is a defendant in suits brought in various courts in the United States by plaintiffs who allege that they have suffered personal injury as a result of exposure to asbestos-containing paper machine clothing synthetic dryer fabrics marketed during the period from 1967 to 1976 and used in certain paper mills. We were defending 3,669 claims as of September 30, 2025.

The following table sets forth the number of claims filed, the number of claims settled, dismissed or otherwise resolved, and the aggregate settlement amount during the periods presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in thousands, except number of claims)** | **Opening**<br>**Number of**<br>**Claims** | **Claims**<br>**Dismissed,**<br>**Settled, or**<br>**Resolved** | **New Claims** | **Closing**<br>**Number of**<br>**Claims** | **Amounts Paid to<br>Settle or<br>Resolve** |
| For the period ended December 31, 2024 | 3606 | 10 | 50 | 3646 | $13 |
| **For the period ended September 30, 2025** | **3646** | **23** | **46** | **3669** | $**165** |

---

We anticipate that additional claims will be filed against the Company and related companies in the future but are unable to predict the number and timing of such future claims. Due to the fact that information sufficient to meaningfully estimate a range of possible loss of a particular claim is typically not available until late in the discovery process, we do not believe a meaningful estimate can be made regarding the range of possible loss with respect to pending or future claims and therefore are unable to estimate a range of reasonably possible loss in excess of amounts already accrued for pending or future claims.

While we believe we have meritorious defenses to these claims, we have settled certain claims for amounts we consider reasonable given the facts and circumstances of each case. Our insurance carrier has defended each case and funded settlements under a standard reservation of rights. As of September 30, 2025, we had resolved, by means of settlement or dismissal, 38,074 claims at a total cost of $10.9 million. Of this amount, almost 100% was paid by our insurance carrier, who has confirmed that we have approximately $140 million of remaining coverage under primary and excess policies that should be available with respect to current and future asbestos claims.

The Company's subsidiary, Brandon Drying Fabrics, Inc. ("Brandon"), is also a separate defendant in many of the asbestos cases in which Albany is named as a defendant, despite never having manufactured any fabrics containing asbestos. While Brandon was defending against 7,675 claims as of September 30, 2025, only twelve claims have been filed against Brandon since January 1, 2012, and only $15,000 in settlement costs have been incurred since 2001. Brandon was acquired by the Company in 1999 and has its own insurance policies covering periods prior to 1999. Since 2004, Brandon's insurance carriers have covered 100% of indemnification and defense costs, subject to policy limits and a standard reservation of rights.

In some of these asbestos cases, the Company is named both as a direct defendant and as the "successor in interest" to Mount Vernon Mills ("Mount Vernon"). We acquired certain assets from Mount Vernon in 1993. Certain plaintiffs allege injury caused by asbestos-containing products alleged to have been sold by Mount Vernon many years prior to this acquisition. Mount Vernon is contractually obligated to indemnify the Company against any liability arising out of such products. We deny any liability for products sold by Mount Vernon prior to the acquisition of the Mount Vernon assets. Pursuant to its contractual indemnification obligations, Mount Vernon has assumed the defense of these claims. On this basis, we have successfully moved for dismissal in a number of actions.

We currently do not anticipate, based on currently available information, that the ultimate resolution of the aforementioned proceedings will have a material adverse effect on the financial position, results of operations, or cash flows of the Company. Although we cannot predict the number and timing of future claims, based on the foregoing factors, the trends in claims filed against us, and available insurance, we also do not currently anticipate that potential future claims will have a material adverse effect on our financial position, results of operations, or cash flows.

***18. Changes in Shareholders' Equity***

The following tables summarize changes in Shareholders' Equity for the three and nine month period ended September 30, 2025:

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A**<br>**Common Stock** | **Class A**<br>**Common Stock** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Class A**<br>**Treasury Stock** | **Class A**<br>**Treasury Stock** | **Noncontrolling Interest** | **Total Shareholders' Equity** |
| | **Shares** | **Amount** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Shares** | **Amount** | **Noncontrolling Interest** | **Total Shareholders' Equity** |
| **June 30, 2025** | **40984** | $**41** | $**456587** | $**1075934** | $**(144292)** | **11516** | $**(499658)** | $**5497** | $**894109** |
| Net income/(loss) |  |  |  | (97760) |  |  |  | 122 | (97638) |
| Stock issued under incentive compensation plans | 5 |  |  |  |  |  |  |  |  |
| Taxes paid in lieu of share issuance |  |  | (137) |  |  |  |  |  | (137) |
| Stock-based compensation |  |  | 3844 |  |  |  |  |  | 3844 |
| Purchase of Treasury shares (a) |  |  |  |  |  | 810 | (50516) |  | (50516) |
| Dividends declared on Class A Common Stock, $0.27 per share |  |  |  | (7739) |  |  |  |  | (7739) |
| Cumulative translation adjustments |  |  |  |  | 2395 |  |  | 90 | 2485 |
| Pension and postretirement liability adjustments |  |  |  |  | 473 |  |  |  | 473 |
| Derivative valuation adjustment and other |  |  |  |  | 126 |  |  |  | 126 |
| **September 30, 2025** | **40989** | $**41** | $**460294** | $**970435** | $**(141298)** | **12326** | $**(550174)** | $**5709** | $**745007** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A<br>Common Stock** | **Class A<br>Common Stock** | **Additional paid-in capital** | **Retained <br>earnings** | **Accumulated items of other comprehensive income** | **Class A<br>Treasury Stock** | **Class A<br>Treasury Stock** | **Noncontrolling Interest** | **Total Shareholders' Equity** |
| | **Shares** | **Amount** | **Additional paid-in capital** | **Retained <br>earnings** | **Accumulated items of other comprehensive income** | **Shares** | **Amount** | **Noncontrolling Interest** | **Total Shareholders' Equity** |
| **December 31, 2024** | **40917** | $**41** | $**452933** | $**1065763** | $**(195989)** | **9845** | $**(379210)** | $**5409** | $**948947** |
| Net income/(loss) |  |  |  | (71222) |  |  |  | 265 | (70957) |
| Stock issued under incentive compensation plans | 61 |  | (1067) |  |  |  |  |  | (1067) |
| Taxes paid in lieu of share issuance |  |  | (1454) |  |  |  |  |  | (1454) |
| Stock-based compensation |  |  | 9122 |  |  |  |  |  | 9122 |
| Shares issued to Directors' | 11 |  | 760 |  |  |  |  |  | 760 |
| Purchase of Treasury shares (a) |  |  |  |  |  | 2481 | (170964) |  | (170964) |
| Dividends declared on Class A Common Stock, $0.81 per share |  |  |  | (24025) |  |  |  |  | (24025) |
| Dividends paid to noncontrolling interests |  |  |  |  |  |  |  | (88) | (88) |
| Cumulative translation adjustments |  |  |  |  | 58366 |  |  | 35 | 58401 |
| Pension and postretirement liability adjustments |  |  |  |  | (3044) |  |  |  | (3044) |
| Derivative valuation adjustment and other |  |  |  | (81) | (631) |  |  | 88 | (624) |
| **September 30, 2025** | **40989** | $**41** | $**460294** | $**970435** | $**(141298)** | **12326** | $**(550174)** | $**5709** | $**745007** |

---

The following table summarizes changes in Shareholders' Equity for the three and nine month period ended September 30, 2024:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A**<br>**Common Stock** | **Class A**<br>**Common Stock** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Class A**<br>**Treasury Stock** | **Class A**<br>**Treasury Stock** | **Noncontrolling Interest** | **Total <br>Shareholders' Equity** |
|<br>**(in thousands)** | **Shares** | **Amount** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Shares** | **Amount** | **Noncontrolling Interest** | **Total <br>Shareholders' Equity** |
| **June 30, 2024** | **40908** | $**41** | $**452461** | $**1046612** | $**(166907)** | **9662** | $**(364665)** | $**5806** | $**973348** |
| Net income/(loss) |  |  |  | 18029 |  |  |  | 192 | 18221 |
| Compensation and benefits paid or payable in shares | 9 |  | 195 |  |  |  |  |  | 195 |
| Dividends declared on Class A Common Stock, $0.26 per share |  |  |  | (8127) |  |  |  |  | (8127) |
| Initial equity related to Noncontrolling interest in Arcari |  |  |  |  |  |  |  | (166) | (166) |
| Cumulative translation adjustments |  |  |  |  | 16931 |  |  | (153) | 16778 |
| Pension and postretirement liability adjustments |  |  |  |  | (623) |  |  |  | (623) |
| Derivative valuation adjustment |  |  |  |  | (2950) |  |  |  | (2950) |
| **September 30, 2024** | **40917** | $**41** | $**452656** | $**1056514** | $**(153549)** | **9662** | $**(364665)** | $**5679** | $**996676** |

---

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A**<br>**Common Stock** | **Class A**<br>**Common Stock** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Class A**<br>**Treasury Stock** | **Class A**<br>**Treasury Stock** | **Noncontrolling Interest** | **Total <br>Shareholders' Equity** |
|<br>**(in thousands)** | **Shares** | **Amount** | **Additional paid-in capital** | **Retained** <br>**earnings** | **Accumulated items of other comprehensive income** | **Shares** | **Amount** | **Noncontrolling Interest** | **Total <br>Shareholders' Equity** |
| **December 31, 2023** | **40856** | $**41** | $**448218** | $**1010942** | $**(133168)** | **9662** | $**(364665)** | $**5952** | $**967320** |
| Net income/(loss) |  |  |  | 69944 |  |  |  | 366 | 70310 |
| Compensation and benefits paid or payable in shares | 51 |  | 3535 |  |  |  |  |  | 3535 |
| Shares issued to Directors' | 10 |  | 903 | 0 |  |  |  |  | 903 |
| Class A Common Stock, $0.78 per share |  |  |  | (24372) |  |  |  |  | (24372) |
| Inital equity related to Noncontolling interest in Arcari |  |  |  | 0 |  |  |  | (166) | (166) |
| Cumulative translation adjustments |  |  |  |  | (12472) |  |  | (473) | (12945) |
| Pension and postretirement liability adjustments |  |  |  | 0 | 5 |  |  |  | 5 |
| Derivative valuation adjustment |  |  |  |  | (7914) |  |  |  | (7914) |
| **September 30, 2024** | **40917** | $**41** | $**452656** | $**1056514** | $**(153549)** | **9662** | $**(364665)** | $**5679** | $**996676** |

---

(a)In 2021, the Company's Board of Directors authorized the Company to repurchase shares of up to $200 million through open market purchases, privately negotiated transactions or otherwise, and to determine the prices, times and amounts. On February 21, 2025, the Company's Board of Directors authorized the Company to repurchase shares up to $250 million (excluding any fees, commissions, taxes or other expenses related to such purchases), which replaced the 2021 authorization. In 2025, the Company repurchased 2,480,769 shares totaling $171.0 million including excise taxes and fees.

***19. Subsequent Events***

We evaluated subsequent events through the issuance date of these financial statements in Form 10-Q.

On October 28th, 2025, the Company announced that it is exploring strategic alternatives for its structures assembly business, including a potential sale of all or a part of the business at the Amelia Earhart Drive Facility in Salt Lake City. As part of the strategic alternatives, Albany is in ongoing discussions with its customer about potential contract modifications to offset these cost increases.

No other material subsequent events were identified that require disclosure.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

Management's Discussion and Analysis ("MD&A") is intended to help the reader understand the results of operations and financial condition of the Company. MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and the accompanying Notes.

**Forward-looking Statements**

This quarterly report and the documents incorporated or deemed to be incorporated by reference in this quarterly report contain statements concerning our future results and performance and other matters that are "forward-looking" statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The words "believe," "expect," "anticipate," "intend," "estimate," "project," "forecast," "look for," "will," "should," "guidance," "guide" and similar expressions identify forward-looking statements, which generally are not historical in nature. Because forward-looking statements are subject to certain risks and uncertainties, (including, without limitation, those set forth in the Company's most recent Annual Report on Form 10-K or prior Quarterly Reports on Form 10-Q) actual results may differ materially from those expressed or implied by such forward-looking statements.

There are a number of risks, uncertainties, and other important factors that could cause actual results to differ materially from the forward-looking statements, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conditions in the industries in which our Machine Clothing and Albany Engineered Composites segments compete, along with the general risks associated with macroeconomic conditions, including higher interest rates, inflationary pressures, or the effects of another pandemic, for an extended period of time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Some of the Company's competitors in the Machine Clothing segment have the capability to make and sell paper machines and papermaking equipment as well as other engineered fabrics;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Machine Clothing and Albany Engineered Composites segments are subject to significant risks related to the potential manufacture and sale of defective or non-conforming products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Deterioration of global economic conditions could have an adverse impact on the Company's segments and overall business and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, new and unique risks introduced by the U.S. Government's Department of Defense ("DoD") Cybersecurity Maturity Model Certification ("CMMC") program;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Across the entire Company, increasing labor, raw material, energy, or logistics and costs due to supply chain constraints and inflationary pressures. These challenges have only increased as a result of the ongoing Russia-Ukraine war and the conflict in the Middle East;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unable to maintain effective systems of internal controls while consolidating dispersed corporate functions to our corporate headquarters in New Hampshire;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to attract and retain business and employees may depend on our reputation in the marketplace;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Across both segments, potential port strikes could cause additional disruptions to our supply chain;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Harm caused by changes in our relationships or contracts with suppliers and customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Machine Clothing segment, greater than anticipated declines in the demand for publication grades of paper, or lower than anticipated growth in other paper grades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, longer-than-expected timeframe for the aerospace industry to utilize existing inventories, unanticipated reductions in demand, delays, technical difficulties, and cancellations in aerospace programs that are expected to generate revenue and drive long-term growth;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inability of our Machine Clothing or Albany Engineered Composite segments to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of geopolitical crises, natural disaster, public health crises and epidemics/pandemics, regulatory or otherwise);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in geopolitical conditions impacting countries where the Company does or intends to do business, including the effects of the implementation of trade tariffs on imported goods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to achieve or maintain anticipated profitable growth;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's insurance coverage may be inadequate to cover significant risk exposures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to achieve our strategic initiatives and other goals, including, but not limited to, our sustainability goals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, the estimates and expectations based on aircraft production rates provided by Airbus, Boeing and others;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, risks associated with changes in estimates and assumptions that could result in a decline in program gross margins or turn a profitable program into a loss program;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse impacts from inflation, an economic slowdown or recession and by disruption in capital and credit markets that might impede our access to credit, increase our borrowing costs and impair the financial soundness of our customers and suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expectations regarding our ability to attract, motivate, and retain the workforce necessary to execute our business strategy and other goals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse impacts from fluctuations in foreign currency exchange rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Harm caused by customer purchase reductions, payment defaults or contract non-renewal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, future funding and compliance risks associated with our contracts with government entities, OEM customers or prime contractors on contracts with government entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Costly and disruptive legal disputes and settlements and the Company's ability to provide adequate insurance coverage;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential adverse outcomes from current or future patent infringement claims could materially affect our business operations and financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Costs associated with defending or settling intellectual property disputes could be significant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increasing operational and compliance costs associated with increasing environmental, social and governance regulatory requirements, as well as the risk of noncompliance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Future levels of indebtedness and capital expenditures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impairment of goodwill and other intangible assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse impacts from changes in tax legislation or challenges to our tax positions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cybersecurity incidents or significant computer system compromises or data breaches to our information technology systems, processes, sites and cloud-based providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disruptions or challenges arising from the implementation or upgrading of new information technology systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rapid advancements in artificial intelligence may introduce unforeseen regulatory, ethical, and operational challenges;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Integration of AI technologies may involve data privacy, security, and compliance risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evolving legal frameworks around AI and IP protection could impact our competitive position and innovation strategies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant changes in critical estimates and assumptions related to pension and other post-retirement benefit costs and liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant problems with information systems or networks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to adequately integrate acquired companies into our business systems and processes within the expected timeframe or, failure to or delayed realization of anticipated benefits of the acquisition could adversely impact the Company's business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to adequately protect our proprietary technology or intellectual property, which would allow competitors or others to take advantage of our research and development efforts;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impacts on our stock price and trading volume if securities or industry analysis do not publish research or publish inaccurate or unfavorable research about our business, or by future sales of shares by our existing stockholders and the impact of any changes in cash dividend payments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of shareholder activism on our operations, strategy, and overall performance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other risks and uncertainties detailed in this report and other periodic reports.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the Albany Engineered Composites segment, our exploration and pursuit of strategic alternatives for our structures assembly business may not be successful.

Further information concerning important factors that could cause actual events or results to be materially different from the forward-looking statements can be found in the "Business Environment Overview and Trends" sections of this quarterly report, as well as in the Item 1A-"Risk Factors" section of our most recent Annual Report on Form 10-K. Although we believe the expectations reflected in our other forward-looking statements are based on reasonable assumptions, it is not possible to foresee or identify all factors that could have a material and negative impact on our future performance. The forward-looking statements included or incorporated by reference in this report are made on the basis of our assumptions and analyses, as of the time the statements are made, in light of our experience and perception of historical conditions, expected future developments, and other factors believed to be appropriate under the circumstances.

Except as otherwise required by the federal securities laws, we disclaim any obligations or undertaking to publicly release any updates or revisions to any forward-looking statement contained or incorporated by reference in this report to reflect any change in our expectations with regard thereto or any change in events, conditions, or circumstances on which any such statement is based.

**Business Environment Overview and Trends** 

We conduct our business under two reportable segments: Machine Clothing ("MC") and Albany Engineered Composites ("AEC") each rooted in similar materials sciences know-how that forms a common approach to customer value proposition in design and manufacturability. MC competes on the basis of its deep industry knowledge, customer reputation and customer service and global advanced textile manufacturing capabilities, which has enabled it to develop a robust and market leading product offering that can be tailored to customer-specific requirements. AEC competes on the basis of its innovative technology solutions, extensive composite manufacturing capabilities and capacity that enable it to offer high quality specific part and assembly solutions that achieve its customers' application performance requirements.

AEC has long-term contracts in which the selling price is fixed. In accounting for those contracts, we estimate the profit margin expected at the completion of the contract and recognize a pro-rata share of that profit during the course of the contract using a cost-to-cost approach. Changes in estimated contract profitability will affect revenue and gross profit when a change occurs, which could have a favorable or unfavorable effect on revenue and gross profit in any reporting period. For contracts with anticipated losses, a provision for the entire amount of the estimated remaining loss is charged against income in the period in which the loss becomes known. Contract losses are determined considering all direct and indirect contract costs, exclusive of any selling, general or administrative cost allocations, which are treated as period expenses. Expected losses on projects include losses on contract options that are probable of exercise, excluding profitable options that often follow.

Also, please refer to the Business Environment Overview and Trends in the Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2024. The Annual Report on Form 10-K, along with the Company's other filings, can be found on the Securities and Exchange Commission's website, www.sec.gov, as well as on the Company's website: www.albint.com.

***Machine Clothing Segment***

The MC segment expects revenues to continue to decline for publication grade paper and continued softness in Asia, most significantly in China, in the remainder of 2025 and beyond, however, we see an offsetting effect due to growth in demand across Europe for packaging, and to a lesser degree, tissue grade products. The MC segment's backlog continues to be stable through the third quarter of 2025.

MC believes it is well-positioned in key markets, with high-quality, low-cost production in growth markets, substantially lower fixed costs in mature markets, and continued strength in new product development, technical product support,

------

and manufacturing technology. Some of the markets in which MC's products are sold are expected to have volume trends that are in line with global GDP. MC continues to face pricing pressures in all markets. Despite these market pressures on revenue growth, the MC segment is expected to improve earnings in the future through cost controls and manufacturing productivity efficiencies.

***Albany Engineered Composites Segment***

The AEC segment continues to ramp-up production levels on commercial, defense, and space programs. During the third quarter of 2025, we recognized a $147.3 million change in estimated profitability associated with the performance of the CH-53K contracts, inclusive of a loss reserve adjustment of $98.0 million, as a result of greater than planned labor content and higher material inputs caused by inflation estimated for the duration of the contract. This adjustment represents the estimated full loss anticipated over the remaining eight year life of the program, and we are engaging with our CH-53K customer to discuss potential solutions. In spite of these ongoing discussions, subsequent to the end of the third quarter, we announced that we will commence exploration of alternatives to exit the structures assembly portion of our business, including the CH-53K contract work. In addition to these events, we also updated our labor, material input and scrap assumptions along with estimates of certain other long-term programs that resulted in additional negative cumulative changes in estimated profitability.

On October 28, 2025, we announced that we are exploring strategic alternatives for our structures assembly business. These alternatives include a potential sale of all or a part of the business at our Salt Lake City facility and discussions with our customer about contract modifications. Our exploration of strategic alternatives, including a sale or contract modification, may not result in the identification or consummation of any transaction or contract modification. In addition, the process of exploring strategic and other alternatives may be disruptive to our operations and we may incur substantial expenses associated with identifying and evaluating potential strategic or other alternatives. Any potential transaction and the related valuation would be dependent upon a number of factors that may be beyond our control, including, among other factors, potential counterparties, market conditions and industry trends. Any potential contract modifications would be dependent on negotiations with our customer and other factors that we cannot control. Further, speculation regarding any developments related to the strategic alternatives process could cause our stock price to fluctuate significantly. Failure to identify and pursue these strategic alternatives could have a material adverse effect on our business, financial condition, and results of operations.

AEC believes it has the ability to mitigate raw material and supplier costs by entering into long-term supply agreements. However, in some cases, higher raw material and supplier costs adversely impacted certain firm-fixed price programs resulting in lower program gross margins. The AEC segment may continue to experience similar issues in further quarters as it ramps up production levels on these key programs.

------

**Consolidated Results of Operations**

**Overview of Consolidated Results:**

The following table summarizes our consolidated Net revenues:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** | **% Change** | **% Change** | **2025** | **2024** | **% Change** | **% Change** |
| **Net revenues** | $**261434** | $298386 | (12.4) | % | $**861607** | $943710 | (8.7) | % |
| &nbsp;&nbsp;Gross profit/(loss) | **(49938)** | 90384 | (155.3) | % | **144055** | 311453 | (53.7) | % |
| *Gross profit/(loss) margin* | ***(19.1)*** *%*** | *30.3 %* |  |  | ***16.7*** *%*** | *33.0 %* |  |  |
| **Operating expenses:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | **51905** | 52097 | (0.4) | % | **164219** | 162447 | 1.1 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Technical and research expenses | **11467** | 10844 | 5.7 | % | **35915** | 35369 | 1.5 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring expenses, net | **3197** | 2272 | 40.7 | % | **9895** | 6584 | 50.3 | % |
| Total operating expenses | **66569** | 65213 | 2.1 | % | **210029** | 204400 | 2.8 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*Total operating expenses as a percentage of net revenues* | ***25.5*** *%*** | *21.9 %* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*361 bp* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*361 bp* | ***24.4*** *%*** | *21.7 %* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*272 bp* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*272 bp* |
| **Operating income/(loss)** | **(116507)** | **25171** | (562.9) | % | **(65974)** | 107053 | (161.6) | % |
| Interest expense, net | **5897** | 2411 | 144.6 | % | **14702** | 8680 | 69.4 | % |
| Other (income)/expense, net | **(347)** | 3257 | (110.7) | % | **4170** | 5932 | (29.7) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Income/(loss) before income taxes | **(122057)** | 19503 | (725.8) | % | **(84846)** | 92441 | (191.8) | % |
| Income tax expense/(benefit) | **(24419)** | 1282 | (2004.8) | % | **(13889)** | 22131 | (162.8) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*Reported income tax rate* | ***20.0*** *%*** | *6.6 %* | *1341* | *bp* | ***16.4*** *%*** | *23.9 %* | *(753)* | *bp* |
| Net income/(loss) | $**(97638)** | $18221 | (635.9) | % | $**(70957)** | $70310 | (200.9) | % |

---

**Net Revenues**

**Three Month Comparison**

Net revenues for the three months ended September 30, 2025 decreased 12.4% compared to the three months ended September 30, 2024, MC's net revenues declined as a result of reduced demand in Asia, most significantly in China, while sales in all other regions remained stable. Net revenues declines in AEC were driven by revenue adjustments to the CH-53K program based on our long-term contract estimates, partially offset by higher activity levels on the LEAP program.

**Nine Month Comparison**

Net revenues for the nine months ended September 30, 2025 decreased 8.7% as compared to the nine months ended September 30, 2024, MC's net revenues declined as a result of reduced demand in Asia, most significantly in China, an unplanned equipment downtime in one of our production facilities. Further, full-year sales declines occurred in AEC, as a result of $54.3 million of adjustments to the CH-53K program based on our long-term contract estimates. Changes in currency translation rates decreased comparative segment net revenues by $4.0 million as compared to the prior year. AEC revenue declines are partially offset by higher activity levels on the LEAP program.

**Gross Profit**

**Three Month Comparison**

The decrease in gross profit for the three months ended September 30, 2025, as compared to the three months ended September 30, 2024, was driven by increased cost assumptions that adjusted the expected profitability of the AEC segment's CH-53K long-term contracts and resulted in the recording of an expected loss provision of $147.3 million.

**Nine Month Comparison**

The decrease in gross profit for the nine months ended September 30, 2025, as compared to the nine months ended September 30, 2024, was driven by increased cost assumptions that adjusted the expected profitability of certain long-term contracts in the AEC segment resulted in the recording of an expected loss provision of $157.6 million.

------

**Selling, General, and Administrative ("SG&A")**

**Three Month Comparison**

Consolidated SG&A expenses decreased $0.2 million or 0.4% as compared to the three months ended September 30, 2024, primarily due to increased integration costs incurred in the prior year associated with the Heimbach acquisition.

**Nine Month Comparison**

Consolidated SG&A expenses increased $1.8 million or 1.1% as compared to the nine months ended September 30, 2024, primarily resulting from increases in global information services costs to improve security and employee productivity.

**Technical and Research Expenses**

**Three and Nine Month Comparison**

Consolidated Technical and research expenses increased by $0.6 million as compared to the three and nine months ended September 30, 2024, primarily due to new business ventures initiatives in 2025.

**Restructuring Expense, net**

**Three Month Comparison** 

Restructuring expense of $3.2 million in the three months ended September 30, 2025 were $0.9 million higher than expenses of $2.3 million in the three months ended September 30, 2024. Restructuring actions for the three month period are primarily a result of workforce reorganizational costs.

**Nine Month Comparison**

Restructuring expense, net, of $9.9 million in the nine months ended September 30, 2025, increased by $3.3 million compared to $6.6 million in the nine months ended September 30, 2024. The change in restructuring actions for the nine month period are a result of workforce reductions, reorganizational costs, fixed asset impairments, and inventory write-off costs, offset by a pension curtailment gain.

**Interest Expense, net**

Interest expense, net, increased over the prior year primarily due to higher average debt balances, in part offset by a larger amount of interest income earned on cash equivalents during the current year.

**Other (Income)/Expense, net**

Other (income)/expense, net, included foreign currency related transactions which resulted in gains of $1.1 million and losses of $7.8 million in the three and nine months ended September 30, 2025, as compared to losses of $1.8 million and $0.7 million in the same periods last year. These changes were primarily the result of unrealized losses and gains on intercompany loans. In addition, changes in the fair value of derivative instruments included gains of $0.1 million and $3.4 million in the three and nine months ended September 30, 2025, as compared to gains of $0.5 million and losses of $3.8 million for the three and nine months ended September 30, 2024. Unrealized gains and losses on both derivative instruments and intercompany loans were driven by currency rate movements, most notably the Brazilian Real and Mexican Peso. Other (income)/expense, net also included a gain of $1.6 million from the divestiture of Arcari during the nine months ended September 30, 2025.

**Effective Income Tax Rate**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Effective income tax rate | **20.0%** | 6.6% | **16.4%** | 23.9% |

---

The Company has operations that constitute a taxable presence in 22 countries outside of the United States. The majority of these countries had income tax rates that were above the United States federal tax rate of 21 percent during the periods reported. The jurisdictional location of earnings is a significant component of our effective tax rate each year. The rate impact of this component is influenced by the specific location of non-U.S. earnings and the level of our total earnings. From period to period, the jurisdictional mix of earnings can vary as a result of operating

------

fluctuations in the normal course of business, as well as the extent and location of other income and expense items, such as pension settlement and restructuring charges.

The tax rate is affected by recurring items, such as the income tax rate in the U.S. and non-U.S. jurisdictions and the mix of pre-tax income earned in those jurisdictions. The tax rate is also affected by U.S. tax costs on foreign pre-tax earnings, and by discrete items that may occur in any given year but are not consistent from year to year. The Company's effective tax rate for the third quarter of 2025 was 20.0%, compared to 6.6% for the same period in 2024, mainly due to favorable discrete tax adjustments in the prior period exceeding favorable discrete tax adjustments in the current period. For more information, see *Note 7, Income Taxes,* in the Notes to the Consolidated Financial Statements.

The Organization for Economic Co-operation and Development has issued Pillar Two model rules introducing a new global minimum tax of 15 percent intended to be effective on January 1, 2024. While the U.S. has not yet adopted the Pillar Two rules, various other governments around the world are enacting legislation. As currently designed, Pillar Two will ultimately apply to our worldwide operations. Although we do not expect these rules to materially increase our global tax costs in 2025, there remains uncertainty as to the final Pillar Two model rules. We will continue to monitor U.S. and global legislative action related to Pillar Two for potential impacts.

On July 4, 2025, the One Big Beautiful Bill (OBBB) Act, which includes a broad range of tax reform provisions, was signed into law in the United States and we continue to assess its impact.

**Segment Results of Operations**

**Segment Revenues and Gross Profit:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** | **% Change** | **2025** | **2024** | **% Change** |
| **Segment net revenues** |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**174950** | $183033 | (4.4)% | $**530573** | $561828 | (5.6)% |
| &nbsp;&nbsp;Albany Engineered Composites | $**86484** | $115353 | (25.0)% | $**331034** | $381882 | (13.3)% |
| Consolidated total | $**261434** | $298386 | (12.4)% | $**861607** | $943710 | (8.7)% |
| **Segment Gross profit** |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**82070** | $88921 | (7.7)% | $**245731** | $262449 | (6.4)% |
| &nbsp;&nbsp;Albany Engineered Composites | $**(132008)** | $1463 | (9123.1)% | $**(101676)** | $49004 | (307.5)% |
| Consolidated total | $**(49938)** | $90384 | (155.3)% | $**144055** | $311453 | (53.7)% |
| **Segment Gross profit margin** |  |  |  |  |  |  |
| &nbsp;&nbsp;*% of Segment net revenues - MC* | ***46.9*** *%*** | *48.6 %* |  | ***46.3*** *%*** | *46.7 %* |  |
| &nbsp;&nbsp;*% of Segment net revenues - AEC* | ***(152.6)*** *%*** | *1.3 %* |  | ***(30.7)*** *%*** | *12.8 %* |  |
| &nbsp;&nbsp;*% of Consolidated net revenues* | ***(19.1)*** *%*** | *30.3 %* |  | ***16.7*** *%*** | *33.0 %* |  |

---

**Machine Clothing Segment** 

**Three Month Comparison**

For the three months ended September 30, 2025, MC segment net revenues decreased $8.1 million or 4.4% as compared to the three months ended September 30, 2024, driven by reduced demand in Asia, particularly in China while all other regions remained stable. In addition, changes in currency translation rates had the effect of decreasing segment net revenues $2.6 million.

For the three months ended September 30, 2025, MC segment gross profit decreased by $6.9 million, primarily the result of lower revenues during the third quarter of 2025 as the gross profit margin decreased to 46.9% compared to 48.6% for the three months ended September 30, 2024. Gross margin was primarily impacted by lower Asia sales volume partially offset by the benefits of ongoing footprint optimization initiatives. Going forward, we will continue to execute our plan of rationalizing production across our network of facilities in order to realize productivity movements.

**Nine Month Comparison**

For the nine months ended September 30, 2025, MC segment net revenues decreased $31.3 million or 5.6% as compared to the nine months ended September 30, 2024, driven by reduced demand in Asia, particularly in China,

------

and an unplanned equipment downtime in one of our production facilities. In addition, changes in currency translation rates decreased comparative segment net revenues by $3.1 million as compared to the prior year.

For the nine months ended September 30, 2025, MC segment gross profit decreased by $16.7 million, primarily the result of lower revenues during the nine months of 2025 and unplanned equipment downtime in one of our facilities.

**Albany Engineered Composites ("AEC") Segment** 

**Three Month Comparison**

For the three months ended September 30, 2025, segment net revenues decreased $28.9 million or 25.0% as compared to the three months ended September 30, 2024. This decrease is primarily driven by $46.0 million of revenue adjustments to the CH-53K program based on our long-term contract estimates. These reductions are partially offset by higher activity levels in the LEAP program.

AEC is party to contracts with certain customers, including its contract for the LEAP program, where revenue is determined by a cost-plus-fee agreement. Revenue earned under these arrangements accounted for approximately 50 percent and 33 percent of segment revenue for the three months ended September 30, 2025 and September 30, 2024, respectively.

For the three months ended September 30, 2025, segment gross profit decreased $133.5 million as compared to the three months ended September 30, 2024. This decrease in gross profit was driven primarily by approximately $147.3 million of increased life of contract cost assumptions surrounding the estimated profitability of our CH-53K long-term contracts. For the three months ended September 30, 2024, adjustments in the estimated profitability of long-term contracts decreased segment gross profit $13.3 million. Subsequent to quarter end, the Company announced that it has initiated a strategic review of its structures assembly business, including the CH-53K program and its production site. The strategic review may include a potential sale of all or part of the site.

**Nine Month Comparison**

For the nine months ended September 30, 2025, segment net revenues decreased $50.8 million or 13.3% as compared to the nine months ended September 30, 2024. This decrease is primarily driven by $54.3 million of revenue adjustments to the CH-53K program based on our long-term contract estimates. These reductions are partially offset by higher activity levels in the LEAP program.

AEC is party to contracts with certain customers, including its contract for the LEAP program, where revenue is determined by a cost-plus-fee agreement. Revenue earned under these arrangements accounted for approximately 37 percent and 40 percent of segment revenue for the first nine months of 2025 and 2024, respectively.

For the nine months ended September 30, 2025, segment gross profit decreased $150.7 million as compared to the nine months ended September 30, 2024. This decrease in gross profit was driven primarily by changes in the estimated profitability of our CH-53K and other long-term contracts, including the recognition of an estimated loss reserve on CH-53K, which decreased gross profit by $157.6 million and $13.3 million in 2025 and 2024, respectively due to increased material, labor, and overhead cost assumptions. For the nine months ended September 30, 2024, adjustments in the estimated profitability of long-term contracts decreased segment gross profit $28.3 million.

------

**Segment Operating Expenses, Segment Operating Income/(loss):**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **(in thousands, except percentages)** | **2025** | **2024** | **% Change** | **% Change** | **2025** | **2024** | **% Change** | **% Change** |
| Segment selling, general and administrative expenses |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**30291** | $32048 | (5.5) | % | $**98841** | $95384 | 3.6 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***17.3*** *%*** | *17.5 %* | *(20)* | *bp* | ***18.6*** *%*** | *17.0 %* | *165* | *bp* |
| &nbsp;&nbsp;Albany Engineered Composites | $**12218** | $11923 | 2.5 | % | $**34121** | $36249 | (5.9) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***14.1*** *%*** | *10.3 %* | *379* | *bp* | ***10.3*** *%*** | *9.5 %* | *82* | *bp* |
| &nbsp;&nbsp;Corporate | $**9396** | $8126 | 15.6 | % | $**31257** | $30814 | 1.4 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Consolidated net revenues* | ***3.6*** *%*** | *2.7 %* | *87* | *bp* | ***3.6*** *%*** | *3.3 %* | *36* | *bp* |
| Consolidated total selling, general and administrative expenses | $**51905** | $52097 | (0.4) | % | $**164219** | $162447 | 1.1 | % |
| Segment technical and research expenses |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**6716** | $7042 | (4.6) | % | $**21332** | $22066 | (3.3) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***3.8*** *%*** | *3.8 %* | *(1)* | *bp* | ***4.0*** *%*** | *3.9 %* | *9* | *bp* |
| &nbsp;&nbsp;Albany Engineered Composites | $**3673** | $3802 | (3.4) | % | $**11472** | $13303 | (13.8) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***4.2*** *%*** | *3.3 %* | *95* | *bp* | ***3.5*** *%*** | *3.5 %* | *(2)* | *bp* |
| &nbsp;&nbsp;Corporate | $**1078** | $0 |  | % | $**3111** | $0 |  | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Consolidated net revenues* | ***0.4*** *%*** | *— %* | *41* | *bp* | ***0.4*** *%*** | *— %* | *36* | *bp* |
| Consolidated total technical and research expenses | $**11467** | $10844 | 5.7 | % | $**35915** | $35369 | 1.5 | % |
| Segment restructuring expenses, net |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**1960** | $2207 | (11.2) | % | $**6322** | $3294 | 91.9 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***1.1*** *%*** | *1.2 %* | *(9)* | *bp* | ***1.2*** *%*** | *0.6 %* | *61* | *bp* |
| &nbsp;&nbsp;Albany Engineered Composites | $**113** | $34 | 232.4 | % | $**1801** | $3144 | (42.7) | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Segment net revenues* | ***0.1*** *%*** | *— %* | *10* | *bp* | ***0.5*** *%*** | *0.8 %* | *(28)* | *bp* |
| &nbsp;&nbsp;Corporate | $**1124** | $31 | 3525.8 | % | $**1772** | $146 | 1113.7 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Consolidated net revenues* | ***0.4*** *%*** | *— %* | *42* | *bp* | ***0.2*** *%*** | *— %* | *19* | *bp* |
| Consolidated total restructuring expenses, net | $**3197** | $2272 | 40.7 | % | $**9895** | $6584 | 50.3 | % |
| Segment Operating income/(loss) |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Machine Clothing | $**43103** | $47624 | (9.5) | % | $**119236** | $141705 | (15.9) | % |
| &nbsp;&nbsp;Albany Engineered Composites | $**(148012)** | $(14296) | *935.3* | *%* | $**(149070)** | $(3692) | *3937.6* | *%* |
| &nbsp;&nbsp;Corporate expenses | $**(11598)** | $(8157) | 42.2 | % | $**(36140)** | $(30960) | 16.7 | % |
| Segment Operating income | $**(116507)** | $25171 | (562.9) | % | $**(65974)** | $107053 | (161.6) | % |

---

**Machine Clothing Segment**

**Three Month Comparison**

For the three months ended September 30, 2025, segment operating income decreased as compared to the three months ended September 30, 2024, decreasing $4.5 million or 9.5%. The weaker segment gross profit performance was offset by technical and research expenses and SG&A expenses decreasing by $2.1 million, primarily a result of cost containment and the realization of Heimbach integration synergies.

**Nine Month Comparison**

For the nine months ended September 30, 2025, segment operating income decreased $22.5 million as compared to the first nine months of 2024. The weaker segment operating income performance was impacted by lower gross profit in the current year, as well as general inflationary pressures. This change was slightly offset by a decrease in Heimbach integration costs that occurred in the first nine months of 2024, as this did not recur in 2025.

**Albany Engineered Composites ("AEC") Segment**

**Three Month Comparison**

------

For the three months ended September 30, 2025, segment operating income decreased $133.7 million, principally due to contract loss reserve charges associated with the CH-53K program.

**Nine Month Comparison**

For the nine months ended September 30, 2025, segment operating income/(loss) decreased $145.4 million, principally due to reduced segment gross profit as noted above, offset by a decrease in compensation and personnel-related SG&A expenses and lower restructuring charges.

**Working Capital, Liquidity and Capital Structure**

***Cash Flow Summary***

---

| | | |
|:---|:---|:---|
| | **Nine months ended September 30,** | **Nine months ended September 30,** |
|<br>**(in thousands)** | **2025** | **2024** |
| Net income/(loss) | $**(70957)** | $70310 |
| &nbsp;&nbsp;Depreciation and amortization | **65480** | 67003 |
| &nbsp;&nbsp;Changes in working capital (a) | **(15108)** | 7700 |
| &nbsp;&nbsp;Changes in other noncurrent liabilities and deferred taxes | **(26171)** | (7569) |
| &nbsp;&nbsp;Other operating items | **125528** | 2541 |
| Net cash provided by operating activities | **78772** | 139985 |
| Net cash used in investing activities | **(45566)** | (61053) |
| Net cash used in financing activities | **(48268)** | (121773) |
| Effect of exchange rate changes on cash and cash equivalents | **8089** | (3357) |
| Decrease in cash and cash equivalents | **(6973)** | (46198) |
| Cash and cash equivalents at beginning of year | **115283** | 173420 |
| Cash and cash equivalents at end of period | $**108310** | $127222 |

---

(a)Includes Accounts receivable, Contract assets, Inventories, Accounts payable, and Accrued liabilities.

Net cash provided by operating activities during the nine months ended September 30, 2025 was $78.8 million, compared to $140.0 million in the nine months ended September 30, 2024. The decrease was primarily driven by a reduction in the gross profit of both segments along with an inventory build in AEC early in the year in anticipation of production ramp. Non-cash adjustments to the CH-53K programs, including loss reserves of $98.0 million, are a component of other operating items within net cash provided by operating activities.

Net cash used in investing activities included capital expenditures totaling $48.8 million and $62.1 million for the nine months ended September 30, 2025 and September 30, 2024, respectively, with investments focused on aerospace program support, continued maintenance capex and capital designed to improve operating efficiencies across the Company.

Net cash used in financing activities was $48.3 million for the nine months ended September 30, 2025 as compared to net cash used of $121.8 million for the nine months ended September 30, 2024. During 2025, we had net borrowings of $150.0 million as compared to net repayments of $94.6 million in the prior year. Additionally, the Company repurchased $171.0 million of share repurchases and paid dividends of $24.7 million in the first nine months of 2025.

***Liquidity and Capital Structure***

We finance our business activities principally with cash generated from operations and borrowings, largely through our revolving credit agreement as discussed below. As of September 30, 2025, $480.6 million of borrowings were outstanding under our $800 million unsecured committed Amended Credit Agreement.

As of September 30, 2025, we had cash and cash equivalents of $108.3 million and borrowing capacity under our Amended Credit Agreement of $319.4 million, for a total liquidity of approximately $427.7 million. We believe cash flows from operations and the availability of funds under our Amended Credit Agreement will be adequate to fund our operations and business needs over the next twelve months.

As of September 30, 2025, $88.7 million of our total cash and cash equivalents were held by non-U.S. subsidiaries. The accumulated undistributed earnings of the Company's foreign operations not targeted for repatriation to the U.S.

------

were in excess of $140.0 million, as of September 30, 2025 and are intended to remain indefinitely invested in foreign operations. Our cash planning strategy includes repatriating current earnings in excess of working capital requirements from certain countries in which our subsidiaries operate. While we have been successful in such endeavor to date, there can be no assurance that we will be able to cost effectively repatriate funds in the future. Repatriating such cash from certain jurisdictions, which is currently considered to be indefinitely reinvested in foreign operations, may also result in additional taxes.

We have also returned cash to shareholders through dividends and share repurchases. During the nine months ended September 30, 2025, we paid $24.7 million in dividends and repurchased 2,480,769 shares for a total cost of $171.0 million, including excise taxes and fees.

Earlier this year, the Company announced that it will be consolidating its corporate headquarters in Portsmouth, NH. This change impacts approximately 100 employees, will take place over the next year and a half, and will cost an estimated $7.0 million over that period related to retention, relocation, severance, and professional costs.

**Off-Balance Sheet Arrangements**

The Company is party to certain off-balance sheet arrangements, including certain guarantees. The Company provides financial assurance, such as payment guarantee and letters of credit and surety bonds, primarily to support workers' compensation programs and customs clearance, of less than $10 million. There were no material changes in the Company's off-balance sheet arrangements during the third quarter of 2025.

------

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

We are exposed to changes in both foreign currency exchange rates and interest rates. From time to time, the Company enters into derivative agreements to manage these risks. The market risk is the potential loss arising from adverse changes in these rates as discussed below.

**Foreign Currency Exchange Rate Risk**

We have manufacturing plants and sales transactions worldwide and, therefore, are subject to foreign currency risk. Our operational results can be materially impacted depending on the volatility and magnitude of foreign rate changes. This risk is composed of both potential losses from the translation of foreign currency financial statements and the remeasurement of foreign currency transactions. To manage this risk, we periodically enter into forward exchange contracts either to hedge the net assets of a foreign investment or to provide an economic hedge against future cash flows. The total net assets of non-U.S. operations and long-term intercompany loans denominated in nonfunctional currencies subject to potential loss amount to approximately $599.9 million. The potential loss in fair value resulting from a hypothetical 10% adverse change in quoted foreign currency exchange rates amounts to $59.9 million. Furthermore, related to foreign currency transactions, we have exposure to various nonfunctional currency balances totaling $170.4 million. This amount includes, on an absolute basis, exposures to assets and liabilities held in currencies other than our local entities' functional currencies. On a net basis, we had $41.0 million of foreign currency assets as of September 30, 2025. As currency rates change, these nonfunctional currency balances are revalued, and the corresponding adjustment is recorded in the income statement. A hypothetical change of 10% in currency rates could result in an adjustment to the income statement of approximately $4.1 million. Actual results may differ from these estimates.

**Interest Rate Risk**

We are exposed to interest rate fluctuations with respect to our variable rate debt, depending on general economic conditions.

On September 30, 2025, we had the following unhedged variable rate debt:

---

| | |
|:---|:---|
| **(in thousands, except interest rates)** | **(in thousands, except interest rates)** |
| Long-term debt: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit agreement borrowings outstanding (due in 2028): |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USD borrowings (end of period all-in interest rate of 6.0%) | 250000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EUR borrowings (end of period all-in interest rate of 3.5%) | 52815 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign bank debt | 0 |
| Total | $302815 |

---

Assuming borrowings were outstanding for an entire year, an increase of one percentage point in weighted average interest rates would increase interest expense by $3.0 million. To manage interest rate risk, we may periodically enter into interest rate swap agreements to effectively fix the interest rates on variable debt to a specific rate for a period of time. See *Note 15. Financial Instruments* in the Notes to the Consolidated Financial Statements in Item 1, which is incorporated herein by reference.

**Item 4. Controls and Procedures**

a) Disclosure controls and procedures.

The principal executive officer and principal financial officer, based on their evaluation of disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that the Company's disclosure controls and procedures are effective for ensuring that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in filed or submitted reports is accumulated

------

and communicated to the Company's management, including its principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in internal control over financial reporting.

There was no change in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

**PART II – OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS**

The information set forth above under *Note 17. Commitments and Contingencies* in Item 1, Notes to Consolidated Financial Statements is incorporated herein by reference.

**Item 1A. Risk Factors**

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

**Issuer Purchases of Equity Securities during the three months ended September 30, 2025**

---

| | | | | |
|:---|:---|:---|:---|:---|
| <u>Period</u> | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced program | Approx. dollar value of shares that may yet be purchased under the program (in thousands) |
| July 1 to July 31, 2025 |  |  |  | 143445 |
| August 1 to August 31, 2025 | 809911 | 61.74 | 809911 | 93445 |
| September 1 to September 30, 2025 |  |  |  | 93445 |
| Total | 809911 | 61.74 | 809911 | $93445 |

---

On February 21, 2025, the Company's Board of Directors authorized the Company to repurchase shares up to $250 million (excluding any fees, commissions, taxes or other expenses related to such purchases), which replaces the 2021 authorization. Share purchases may be made through open market purchases, privately negotiated transactions or otherwise. The program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company's discretion. The timing and amount of any share repurchases will be based on the Company's liquidity, general business and market conditions, debt covenant restrictions and other factors, including alternative investment opportunities and capital structure. In total, the Company has repurchased 2,480,769 shares in 2025 for a total cost including excise taxes and fees of $171.0 million. As of September 30, 2025, we were authorized to repurchase shares up to $93.4 million.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not Applicable.

------

**Item 5. Other Information**

*Securities Trading Plans of Directors and Executive Officers*

During the nine months ended September 30, 2025, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Albany International Corp. securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."

------

**Item 6. Exhibits**

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 31.1 | <u>[Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.](ain-20250930xex31111.htm)</u> |
| 31.2 | <u>[Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.](ain-20250930xex31211.htm)</u> |
| 32.1 | <u>[Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code).](ain-20250930xex32111.htm)</u> |
| 101.INS | XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | XBRL Taxonomy Extension Schema Document. |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **ALBANY INTERNATIONAL CORP.** |
| | | **(Registrant)** |
| Date: November 6, 2025 | By | /s/ Willard C. Station |
| | | Willard C. Station<br>Executive Vice President, Chief Financial Officer<br>(Principal Financial Officer) |

---

## Exhibit 31.1

**EXHIBIT (31.1)**

**CERTIFICATION PURSUANT TO**

**RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Gunnar Kleveland, certify that:

1. I have reviewed this report on Form 10-Q of Albany International Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 6, 2025 | By | /s/ Gunnar Kleveland |
| | | Gunnar Kleveland<br>President and Chief Executive Officer<br>(Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT (31.2)**

**CERTIFICATION PURSUANT TO**

**RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Willard Station, certify that:

1. I have reviewed this report on Form 10-Q of Albany International Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 6, 2025 | By | /s/ Willard Station |
| | | Willard Station<br>Executive Vice President, Chief Financial Officer<br>(Principal Financial Officer) |

---

## Exhibit 32.1

**EXHIBIT (32.1)**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Albany International Corp. (the Company) on Form 10-Q for the period ending September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the Report), Gunnar Kleveland, President and Chief Executive Officer, and Willard Station, Chief Financial Officer, Executive Vice President, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: November 6, 2025 | /s/ Gunnar Kleveland |
| | Gunnar Kleveland<br>President and Chief Executive Officer<br>(Principal Executive Officer) |
| | /s/ Willard Station |
| | Willard Station<br>Executive Vice President, Chief Financial Officer <br>(Principal Financial Officer) |

---

<br>